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From first principles of phospholipid – apolipoprotein A-I (apo A-I) interactions,
we hypothesized that the amino acid sequence of apo A-I derived from a different species
may exhibit improved properties compared to human apo A-I for the purpose of
incorporation of G protein-coupled receptors (GPCRs) into homogeneous discoidal
lipoprotein particles. We generated apolipoprotein A-I DNA derived from zebrafish
(Danio rerio) using molecular cloning techniques and optimized a heterologous bacterial
expression system, and protein purification and labeling scheme for obtaining high-yields
of pure zebrafish apo A-I. We demonstrated that zebrafish apo A-I forms stable,
homogeneous discoidal lipoprotein particles, which we termed as Nanoscale
Apolipoprotein Bound Bilayers (NABBs).
Using bovine rhodopsin as a model system, we developed a novel method of
rapidly incorporating GPCRs into NABBs – a significant improvement over traditional
methods – requiring less time and materials for receptor reconstitution. The method was
generalized for incorporation of heterologously expressed GPCRs in mammalian cells
available at comparatively lower levels of receptor concentration and purity. A novel

ELISA technique was developed for high-throughput quantification of the incorporated
GPCR in NABBs. We also developed methods to control the ratio of receptor to NABB
and imaged the rhodopsin-NABBs using electron microscopy (EM) to measure
stoichiometry and receptor orientation.
Using a combination of EM imaging and biochemical analyses, we correlated
stability and signaling efficiency of rhodopsin in NABBs with either one or two
receptors. We discovered that the specific activity of G protein coupling for single
rhodopsins sequestered in individual NABBs was nearly identical to that of two
rhodopsins per NABB under conditions where stoichiometry and orientation could be
inferred by electron microscopy imaging. Thermal stability of rhodopsin and CCR5 in
NABBs was superior to the receptors in various detergents commonly used for membrane
protein work. CCR5 in NABBs retained its ability to activate G protein. This work
highlights the NABBs as a promising tool for in-vitro manipulation of GPCR
stoichiometry and biophysical studies of GPCRs in an isolated, native-like, cell-free
system.

The important thing in science is not so much to obtain new facts
as to discover new ways of thinking about them.

-William Lawrence Bragg
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1.0
Introduction

1.1

G Protein-Coupled Receptors

G Protein-Coupled Receptors (GPCRs) are integral transmembrane
proteins that are known to transduce extracellular signals into intracellular
functions and pathways (Filipek, Stenkamp et al. 2003). They form the largest
and one of the most diverse groups of receptor proteins and are encoded by more
than 1,000 genes in the human genome (Howard, McAllister et al. 2001). The
signal transduction machinery in a cell is triggered by binding of an agonist ligand
(or activation by light in the case of rhodopsin) at the extracellular side, followed
by binding and activation of a guanine-nucleotide binding regulatory protein (G
Protein) at the cytoplasmic side. A variety of chemical transmitters can elicit a
cellular response via their related GPCR. These include biogenic amines
(neurotransmitters), amino acids, peptides, lipids, nucleosides and large
polypeptides. GPCRs thus control a wide range of physiological processes such as
neurotransmission, cellular metabolism, secretion, cellular differentiation and
growth, and inflammatory and immune responses (Bouvier 2001).
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Image adapted from http://en.wikipedia.org/wiki/G_protein

heterotrimer is then ready to couple with another GPCR (Step 6).

reassociates with the  subunits to form the G-protein heterotrimer. The G-protein

controlled by accessory proteins (Step 6). In the GDP bound state, the -subunit

converted to GDP by the intrinsic enzymatic hydrolysis activity of the -subunit, and

action, which is dependent on the G-protein sub-type. The GTP bound to the -subunit is

(Step 5). The  and/ or -subunits interact with downstream proteins to manifest their

heterotrimeric G-protein to dissociate into the GTP-bound -subunit and the -subunits

GDP for GTP by the -subunit of the G-protein (Step 4). Uptake of GTP causes the

conformational change during activation of the GPCR (Step 3) catalyzes an exchange of

GPCR is activated by an extracellular ligand, or in case of rhodopsin, by light (Step 2). A

In the inactive state the G-protein contains a GDP bound to its -subunit (Step 1). The

proteins. GPCRs activate a heterotrimeric guanine-linked protein (G-protein) inside the cell.

G-Protein Coupled Receptors (GPCRs) are seven-transmembrane helix containing

Figure 1-1. Signal Transduction by G Protein-Coupled Receptors

Figure 1-1
Figure 1-1. Signal Transduction by G Protein-Coupled
Receptors
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Not surprisingly, GPCRs are targets of a large number of therapeutic
agents. It is estimated that 50% of all modern drugs (Howard, McAllister et al.
2001) and almost one-quarter of the top 200 best-selling drugs in the year 2000
modulated GPCR activity (George, O'Dowd et al. 2002).
The membrane topology of GPCRs consists of a characteristic
hydrophobic core of seven transmembrane -helices (Suryanarayana, von
Zastrow et al. 1992), an extracellular amino-terminal segment and a cytoplasmic
carboxy-terminal tail. Some GPCRs bear amine-linked glycosylation sites near
their amino terminal tails. Ligand binding to GPCRs involves multiple
interactions between functional groups and specific amino acids in the
extracellular domains and/or the hydrophobic transmembrane core. Till recently,
these interactions were well defined for only a few GPCRs (Bockaert and Pin
1999). Over the last year, there have been an increasing number of reports of high
resolution X-ray crystal structures of GPCRs (Cherezov, Rosenbaum et al. 2007;
Jaakola, Griffith et al. 2008; Scheerer, Park et al. 2008; Shimamura, Hiraki et al.
2008; Warne, Serrano-Vega et al. 2008). These structures have confirmed some
key differences in structural elements compared with the prototypical GPCR –
bovine rhodopsin (Palczewski 2000; Huber, Menon et al. 2008), but have not
been able to adequately explain the dynamic regulation and mechanism of action
of the active state of the GPCR.
Classically, the basic unit of signal transduction comprises the receptor, a
heterotrimeric G protein and a downstream effector component. Binding of a

4

ligand promotes allosteric interactions between the receptor cytoplasmic side and
the GDP-bound trimeric G protein leading to the release of GDP and binding of
GTP to the -subunit. This destabilizes the trimeric complex, causing the
dissociation of the G.GTP and the G dimer. The G.GTP, the G dimer or both,
in turn interact with and modulate the effector component, often involving a
second messenger. Termination of the signal occurs upon hydrolysis of GTP to
GDP due to the GTPase activity of the G subunit, aided by other GTPase
activating proteins (GAPs). The signaling state of the receptor may be turned off
either by ligand dissociation from the active conformation of the GPCR (in the
case of rhodopsin), or phosphorylation of the cytoplasmic side followed by
binding of a protein that is not G protein, or by receptor internalization into the
cell.
GPCRs have been classified into various subclasses based upon
differences in the N and C-terminal regions and insertions in the cytoplasmic loop
regions (Bockaert and Pin 1999). Rhodopsin is a defining member of family 1 (or
family A) GPCRs characterized by comparatively short N- and C-termini. This
family includes 2-adrenergic receptor, chemokine receptors, dopamine receptors
and serotonin (5-HT) receptors. Most of the family A GPCRs have a
palmitoylated cysteine in the C-terminal tail which serves as an anchor to the
membrane. Family A GPCRs were all initially assumed to be monomeric, but
some were able to form homodimers or heterodimers with another GPCR of the
same class via their C-termini, or via contacts between the two 7TM cores
(Chabre and le Maire 2005). Family 2 (or family B) GPCRs have a relatively long

5

N-terminal region which contains several cysteines forming a network of disulfide
bridges, e.g- glucagon receptor. They are not palmitoylated at the C-terminus,
unlike family 1. Family 3 (or family C) GPCRs have a long N-terminal extension
folded in a separate extracellular domain as well as a C-terminal extension, e.g.metabotropic glutamate receptor and the GABAB receptor. Family C GPCRs form
constitutive homo or heterodimers, linked by disulfide bridges and associated
mainly by their large extracellular domains, which include the ligand binding site.
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This figure was adapted from Menon et al. (Menon, Han et al. 2001).

apoprotein.

G protein, transducin. Meta-II eventually decays to free all-trans-retinal and free opsin

Meta-II is the ‘active’ state of the GPCR and is able to catalyze GTP uptake by its cognate

characterized by a de-protonated Schiff base imine and a blue-shifted absorbance at 380nm.

physiological conditions, Meta-I is in a dynamic equilibrium with Meta-II, which is

stabilization by its counterion Glu-113, through metarhodopsin-I (Meta-I). Under

intermediates (Lewis and Kliger 2000). The Schiff-base imine remains protonated due to

ultrafast timescale. The photolyzed pigment then proceeds through a series of spectral

dark state (adapted from (Sakmar 2002)). Photoisomerization of 11-cis-retinal occurs on an

derivative of vitamin A1. The structure in the center of the cycle represents rhodopsin in its

Schiff-base linkage with Glu-113 serving as the counterion. The retinal chromophore is a

Rhodopsin in the dark state has 11-cis-retinal bound to Lys 296 via a protonated

Figure 1-2. Rhodopsin Photocycle and Crystal Structure

Figure 1-2

Figure 1-2. Rhodopsin Photocycle and Crystal Structure

8

1.1.1 Rhodopsin as the prototypical GPCR

The dim-light visual receptor rhodopsin stands out as a model system for
GPCRs, both in terms of GPCR structure and the downstream G protein signaling
mechanism. Rhodopsin is located in the outer segments of retinal rod cells.
Bovine rhodopsin is easily accessible, available in relatively large amounts and
has an available high-resolution structure solved by X-ray crystallography
(Palczewski, Kumasaka et al. 2000; Filipek, Teller et al. 2003). Rhodopsin in its
dark state has the chromophore 11-cis-retinal covalently linked with Lys296 on
helix 7 via a protonated Schiff base linkage, with Glu113 serving as the counterion for the Schiff Base (Menon, Han et al. 2001). 11-cis-retinal serves as an
inverse agonist and keeps the receptor in the inactive conformation in the dark.
Bovine rhodopsin is sufficiently stable in the dark to be further purified by
various chromatographic procedures and is thermally stable in solubilized form in
a variety of detergents (De Grip 1982; Okada, Takeda et al. 1998).
Upon absorption of a photon, the bound chromophore 11-cis-retinal
undergoes a cis-trans conformational switch, which brings about a shift in the
transmembrane helices. The isomerization of retinal leads to a series of
conformational changes in the transmembrane helices (Farrens, Altenbach et al.
1996), which include a counter-ion switch from Glu113 to Glu181 (Yan, Kazmi et
al. 2003) to form metarhodopsin I (pre-active state), deprotonation of the Schiff
Base to form the active state- metarhodopsin II (Fig. 1-2) and the disruption of a
critical salt-bridge between Lys296 and Glu113 (Cohen, Oprian et al. 1992) to

9

form opsin. Metarhodopsin II (Meta-II) interacts with a G protein, called
transducin, and activates it. This in turn activates (by de-inhibiting) a
photoreceptor cGMP-specific phosphodiesterase (Stryer, Hurley et al. 1983).
It is anticipated that the phototransduction signaling pathway involving
rhodopsin and transducin will be the first G protein-coupled pathway for which a
complete molecular description is ultimately available (Ridge, Abdulaev et al.
2003).

1.1.2 Chemokine Receptors

Chemokine receptors are members of family A GPCRs and of significant
clinical importance. Chemokines (chemotactic cytokines) constitute a superfamily
of structurally related small proteins, less than 100 residues in length that are
implicated in the control of a large variety of biological processes including
inflammation, immunosurveillance, viral infection and cancer (Gerard and Rollins
2001). Chemokines mediate their effects by binding to the chemokine receptors
(Berger, Murphy et al. 1999; Rossi and Zlotnik 2000). The CXC and CC
chemokines belong to different subfamilies where the two N-terminal cysteines
are separated by a single amino acid and are adjacent to each other respectively.
Examples of CC-chemokines include MIP-1 (Macrophage Inflammatory
Protein-1), MIP-1 and RANTES (Regulated on Activation, Normal T-Cell
Expressed and Secreted). All of these CC-chemokines bind non-selectively to
CCR5 (Rossi and Zlotnik 2000).
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CCR5 is an important co-receptor that is exploited for entry of HIV-1
(Human Immunodeficiency Virus type 1) and is critical for the transmission of
this virus in the body (Berger, Murphy et al. 1999) (Fig. 1-3). A naturally
occurring CCR5 mutant (CCR532) results in a truncated receptor which leads to
protection against HIV-1 in homozygous individuals and markedly reduced
progress towards AIDS in individuals heterozygous for this mutation (Liu, Paxton
et al. 1996; Samson, Libert et al. 1996; O'Brien and Moore 2000). No adverse
health effects have been linked to the non-functional CCR5 in these individuals,
which makes CCR5 a very attractive target for pharmaceutical intervention for the
prevention of HIV/AIDS (O'Brien and Moore 2000). CCR5 homo and
heterodimerization has been reported to have effects on CCR5 mediated HIV
entry into cells. The dominant-negative phenotype of CCR532 over its wild-type
counterpart have been attributed to the propensity of CCR532 to dimerize with
wild-type CCR5 in the ER, thereby promoting intra-cellular retention of the
heterodimers (Benkirane, Jin et al. 1997). An anti-CCR5 antibody that promotes
dimerization has been reported to activate receptor dependent calcium
mobilization and cell migration, but inhibit its use by HIV as a co-receptor for
virus entry (Vila-Coro, Mellado et al. 2000). Heterodimerization of CCR5 with
CCL2 has also been reported to block HIV entry (Rodriguez-Frade, del Real et al.
2004).
A CCR5 to CXCR4 switch has also been reported to accompany the onset
of AIDS (Berger, Murphy et al. 1999). SDF-1 (Stromal cell-Derived Factor-1) is
a CXC-chemokine and is expressed as two functionally identical, alternative
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splice variants: SDF-1 and SDF-1 (Rossi and Zlotnik 2000), and binds to
CXCR4. CXCR4 is expressed in hematopoeitic cell-lines (Zou, Kottmann et al.
1998) and is thought to be involved in signaling responsible in part for stem-cell
maturation, naive T-cell migration to spleen for antigen presentation and other
developmental signaling (Proudfoot 2002). The SDF-1/CXCR4 system has been
implicated in breast and ovarian cancers (Muller 2001; Scotton, Wilson et al.
2002) and brain tumors (Rubin, Kung et al. 2003).
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facilitate HIV entry. Image adapted from Doms et al. (Doms and Trono 2000).

eventually leads to insertion of a fusion peptide in the membrane and membrane fusion to

chemokine receptor (co-receptor) triggers the formation of a helix bundle in gp41, which

protein gp120 binds first to CD4 and then with CCR5 (or CXCR4). Binding to the

(Oppermann 2004). CCR5 is an important co-receptor for HIV entry into cells. The HIV

CCR5 function are shown by filled circles. Illustration taken from Oppermann et al.

helices. The membrane is depicted by the gray box. Amino acids considered critical for

Secondary structure of CCR5 is arranged in the form of putative transmembrane

Figure 1-3. Amino-acid sequence of CCR5 and its role in HIV entry

Figure 1-3

Figure 1-3. Amino-acid sequence of CCR5 and its role in HIV entry
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1.2

Rhodopsin Dimerization

Despite an increasing number of reports of GPCR dimerization, the idea of
rhodopsin existing as dimers in its native state remains one of the most
controversial issues in the GPCR field. In this section, we review some of the
notable experiments performed with rhodopsin pertaining to the nature of its
organization in native and reconstituted systems. A comparison of key assays, and
their possible pitfalls, used to detect dimerization in other GPCRs is also reviewed
(see also section 5.3.4).
Rhodopsin has been historically considered a monomer. One of the first
reports of rhodopsin forming monomers in detergents came from rhodopsin
solubilized in Triton X-100 (H. Beverley Osborne 1974) where it was determined,
using ion-exchange chromatography and analytical ultracentrifugation, that
protein-detergent complexes contained a single protein in approximately 80
detergent molecules. The methods used in this study however, could not
differentiate between a monomer or dimer in a detergent micelle. Determinations
of protein molecular mass in other detergents by small-angle neutron scattering
(Osborne, Sardet et al. 1978) have pointed at monomeric rhodopsin. The study
also found that flash photoactivation of rhodopsin in certain types of polar
detergents induced possible dimerization on a timescale of minutes. The slow
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dimerization was followed by further oligomerization and eventual precipitationa sign of protein denaturation in detergent. Dimerization and oligomerization of
rhodopsin has not been observed in the native ROS membranes in the absence of
detergents using small-angle neutron scattering (Saibil, Chabre et al. 1976).
Formation of rho monomers or oligomers was shown to be dependent on the type
of detergent used for solubilization of ROS (McCaslin and Tanford 1981). The
oligomeric nature could be altered by varying the concentration of these
detergents. In terms of G protein activation, it has been reported that
photoactivated rho and holotransducin form a 1:1 complex in detergent, and that
the photoactivated rho can activate hundreds of transducin molecules (Vuong,
Chabre et al. 1984).
The issue of rhodopsin dimerization came to the forefront of GPCR
research primarily due to observations of associated rhodopsins as a row of
dimers in AFM images of intact mouse disk membranes (Fotiadis, Liang et al.
2003) (Fig. 1-4) and structural characterizations of crystal structures of rhodopsin
(Salom, Lodowski et al. 2006). The dimerization reports have been contested as
sample preparation (lipid phase change induced) problems (Chabre, Cone et al.
2003) or crystallography artifacts. It has also been reported that transducin
activity by rhodopsin dimers and olimers in detergents is significantly higher than
by rhodopsin monomers (Jastrzebska, Maeda et al. 2004; Jastrzebska, Fotiadis et
al. 2006). Moreover, opsin has been reported to be present as dimers on the
surface of heterologously expressing COS cells (Kota, Reeves et al. 2006).
Although the claims of rhodopsin dimerization, and the biological relevance of
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this putative dimerization have been contested (Chabre and le Maire 2005; Ernst,
Gramse et al. 2007), lack of an appropriate system for the study of one and two
rhodopsins free from detergent-related aggregation artifacts and cellular
overexpression have made the answer elusive.
In order to investigate the existence of GPCR dimers in living cells,
several groups have used biophysical assays based on light resonance energy
transfer methods which are fluorescence resonance energy transfer (FRET) that
uses fluorophores, or bioluminescent resonance energy transfer (BRET) using
luciferase or green fluorescent protein (GFP) containing GPCR constructs
(Bouvier 2001; Bartfai, Benovic et al. 2004). Close proximity between GPCRs
containing complementary labels causes energy transfer from a donor to an
acceptor molecule resulting in the appearance (in BRET) or enhancement of the
emission signal (in FRET) of the acceptor molecule. It is plausible that using
comparatively large labels like luciferase and GFP (~25 kD) on GPCRs (~40 kD)
may itself influence trafficking of the GPCR as well as dimerization either
directly or via accessory proteins. Further, constraints on the assumed distance
dependency of these methods have been seen. Heterodimerization between 2adrenergic

receptor

and

-opioid

receptors

were

detected

with

co-

immunoprecipitation but not with BRET and FRET, whereas homodimerization
could be detected with all three methods (McVey, Kellet et al. 2001).
Overexpression of GPCRs in cells has been reported to cause significant BRET
signal attributed to transient, non-specific interactions (James, Oliveira et al.
2006). Finally, the issue of interpreting ligand-mediated dimerization of GPCRs
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in cells is non-trivial. Both BRET and FRET are sensitive to the dipole orientation
of their respective labels and conformational changes induced by ligand binding
may change the dipole orientation such that a signal is seen independent of any
change in the distance between the receptors (Bouvier 2001).
Investigation of dimerization of GPCRs therefore, will benefit from
validation of cell-based assays using a combination of ensemble biochemistry,
single-particle imaging and novel receptor assays in a cell-free system.
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Figure 1-4. AFM Image and Models for Rhodopsin Dimerization

(A) Topographic image of the cytoplasmic side of rhodopsin
obtained by Atomic Force Microscopy (AFM) on native disc membranes.
Rows of rhodopsin dimers are seen in a paracrystalline array. The dashed
ellipse shows isolated dimers and the arrows show rho monomers. The
scale bar is 15nm. Image adapted from Fotiadis et al. (Fotiadis, Liang et
al. 2003). (B) Model of the side view model of a rho dimer. Contact
between the monomers is formed by transmembrane helices IV
(yellowish-green) and V (yellow). The dimer interface consists of
hydrophobic interactions and hydrogen bonds. Model taken from Fotiadis
et al. (Fotiadis, Liang et al. 2004). (C) Model of the packing arrangement
of rho in paracrystalline arrays. Rho assembly in a ‘row of dimers’ state by
contacts between helices IV and V (contact 1). The rows formed by
dimers are highlighted by blue bands. The rows are thought to be formed
due to contacts between the cytoplasmic loop connecting helices V and VI
(C 3) on one dimer and helices I and II (C 1) on the other dimer (contact
2). Rows form paracrystals by extracellular contacts through helix I
(contact 3). Image taken from Liang et al. (Liang, Fotiadis et al. 2003).
(D) Another depiction of the ‘row of dimers’ model. Helix ends are shown
in different colors. Image taken from Fotiadis et al. (Fotiadis, Liang et al.
2004).
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Figure 1-4. AFM Image and Models for Rhodopsin Dimerization
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1.3

The Importance of Lipids

Lipids as a class of molecules display a wide diversity in both
structure and biological function. The propensity of hydrophobic lipid tails to selfassociate (entropically driven by water), and the tendency of the hydrophilic
moieties to interact with aqueous environments and with each other, is the
physical basis of the spontaneous formation of the lipid bilayer membrane. The
membrane is the supporting matrix for a wide spectrum of proteins involved in
many cellular processes. Lipids also allow particular proteins in membranes to
aggregate, and others to disperse. Approximately 20-35% of all proteins are
integral membrane proteins, and probably half of the remaining proteins function
at or near a membrane surface. Because of their relatively reduced state, lipids
are used for energy storage in lipid droplets as triacylglycerol and steryl esters
(van Meer, Voelker et al. 2008). Lipids may also act as first and second
messengers in signal transduction and molecular recognition processes. The
adaptability and flexibility exhibited in membrane structure and function is
possible only with a broad spectrum of lipid mixtures (Dowhan 1997). Therefore,
the physical and chemical properties of the membrane directly affect most cellular
processes making the role of lipids dynamic with respect to cell function rather
than simply defining a static barrier.
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Illustration adapted from Fielding et al. (Fielding and Fielding 1995). EM image of HDL

particles taken from Matz et al. (Matz and Jonas 1982)

seen.

densities similar to that of native HDL particles. Extensive stacking between the planar discs can be

apo A-I and egg-PC lipids. The particles were purified using density gradient centrifugation, at

The inset shows an EM image of reconstituted HDL particles prepared using purified human

spheroidal HDL and dissociates from the complex and is recycled.

LCAT activity converts discoidal HDL to spheroidal HDL. Apo A-I shows lower affinity for

attached enters the plasma where it interacts with Lecithin Cholesterol Acyl Transferase (LCAT).

catalyzed by Phospholipid Transfer Protein (PLTP). The mature discoidal HDL with apo A-I still

cells. The discoidal HDL particle increases in diameter, presumably by addition of FC and PL,

particles while gathering free cholestrol (FC) and phospholipids (PL) from the surface of peripheral

called pre  HDL. These lipid-poor particles fuse with each other and with small discoidal HDL

Delipidated apo A-I interacts with cholesterol-loaded plasma membranes forming lipid-poor particles

Discoidal HDL particles play a physiologically vital role in reverse cholesterol transport.

Figure 1-5. Apo A-I and Reverse Cholesterol Transport

Figure 1-5

Figure 1-5. Apo A-I and Reverse Cholesterol Transport

23

1.3.1 Discoidal HDL Particles to Study Membrane Proteins

The formation of discoidal structures of lipids surrounded by human
apolipoprotein A-I (apo A-I) was first demonstrated in 1980 (Jonas and Drengler
1980), after similar structures were implicated in transport of cholesterol by High
Density Lipoproteins (HDL) in the serum (Jonas, Krajnovich et al. 1977). More
recently, an engineered N-terminal truncated form of human apo A-I was used in
a similar manner to incorporate peripheral and integral membrane proteins into
such bilayer nano discs (Bayburt, Grinkova et al. 2002; Bayburt and Sligar 2002;
Bayburt and Sligar 2003).
Nanoscale discoidal lipoproteins with incorporated GPCRs are an ideal
system for spectroscopy. The discrete lipid discs prevent aggregation phenomena
as seen with detergent micelles, light-scattering of lipid vesicles and provide a
system that can be isolated in monodisperse form with the phospholipid-protein
native structure and function maintained. The nanoscale lipid disc with embedded
protein can be versatilely adapted for assays involving either immobilization or
constant flow of the discs over a surface. The protein-lipid complex will behave
more or less like normal proteins in solution without foaming or sedimentation
problems associated with detergents and vesicles.
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Figure 1-6. X-Ray Crystal Structures of Human Apo A-I

High-resolution x-ray structures are available for human apo A-I
(1-43 amino acids truncated) as well as full-length protein. (A) 4Å
structure of residues 44-243 of human apo A-I from Borhani et al.
(Borhani, Rogers et al. 1997). N-terminal truncation of apo A-I resulted in
crystallization of a tetramer in a unit cell shown in the right panel. Apo AI monomer (left) and dimer (center) are also shown. Dimeric crystal
contacts were formed along helix 10 of two anti-parallel apo A-I
molecules (center). (B) Domain representation of human apo A-I from Li
et al. (Li, Chen et al. 2004). The N-terminal 43 amino-acids are
considered to form a globular, flexible domain and important for
activation of Lecithin Cholesterol Acyl Transferase (LCAT) enzyme in the
reverse cholesterol transport pathway. (C) Domain representation and xray structure of full-length human apo A-I adapted from Ajees et al.
(Ajees, Anantharamaiah et al. 2006). The N-terminus forms a helix among
a four helix bundle. Notably, the structure shows six total helices,
indicating that every proline residue in the sequence may not always cause
kinks in the helices.
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Figure 1-6. X-Ray Crystal Structures of Human Apo A-I
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In-vitro assays avoid several artifacts and assumptions inherent to in-vivo
systems. Detergents offer the first choice to isolate transmembrane proteins from
their cellular context. In a sense, both detergents and lipids are surfactants. What
distinguishes one from the other are the concentration regimes for self-association
and the kinds of multimolecular structures each can make. The problem of
isolating native membrane proteins from lipid bilayers and then subsequently
manipulating them is, in essence, a problem of dealing with mixed surfactant
systems. However most GPCRs retain function in only a limited number of
detergents, which typically have a relatively low critical micelle concentration
and a relatively large micelle size. This gives rise to aggregation phenomena
(Jastrzebska, Maeda et al. 2004) and is a potential source of irreproducibility
while performing spectroscopic measurements. Vesicles form closed structures
and the chemical composition of the lumen is difficult to alter. Lipid vesicles are
also prone to light scattering artifacts in optical spectroscopy and a precise control
of the number of receptors per vesicle, and heterogeneity of vesicle sizes, are
difficulties. A further complication, when the GPCR is reconstituted in a vesicle,
arises from the ‘sidedness’ of GPCR interactions with ligands and G proteins
respectively.
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Figure 1-7. Double-belt Model and Salt-Bridging in Discoidal
Lipoprotein Particles

(A) Molecular model of a ‘double-belt’ conformation of Nterminal 1-43 amino-acid truncated version of human apo A-I with a
simulated POPC bilayer, from Segrest et al. (Segrest, Jones et al. 1999).
The helical ribbons are based on the x-ray structure of N-terminally
truncated human apo A-I (Borhani, Rogers et al. 1997) and arranged
antiparallel with respect to each other with helix 5 of monomer 1
associated with helix 5 of monomer 2 (LL5/5 configuration). (B) Spacefilling molecular graphics model of human apo A-I 1-43, from Segrest et
al. (Segrest, Li et al. 2000). The apo A-I is viewed with the plane of the
disc parallel to the paper. Hydrophobic residues are indicated in orange,
prolines in green, basic residues in blue and acidic residues in red. The
amphipathic nature of the -11/3 ring can be clearly seen in this depiction.
(C) Molecular Dynamics simulation at 4.5 nsec of a single
bacteriorhodopsin embedded in a HDL particle containing DPPC lipids.
The two molecules of human apo A-I 1-43 are shown in blue and red in
this figure from Shih et al. (Shih, Denisov et al. 2005). (D) Structure and
interhelical salt bridging between apo A-I helices arranged in the LL5/5
configuration, taken from Segrest et al. (Segrest, Jones et al. 1999). (E)
Weighed interhelical salt-bridging score analysis of the C-terminal 200
amino acids of human apo A-I and zebrafish apo A-I. 2 molecules of apo
A-I were considered to be in -11/3 helical conformation and the salt
bridging score was computationally calculated using the ALIGN program
in this figure adapted from Segrest et al. (Segrest, Jones et al. 1999). (F)
An example of a salt-bridging triad observed in a apo A-I rotamer by MD
simulation, from Klon et al. (Klon, Segrest et al. 2002).
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Figure 1-7. Double-belt Model and Salt-Bridging in Discoidal
Lipoprotein Particles
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1.4

Signal Transduction Events Proximal to the GPCR

There are no known prokaryotic homologs of GPCRs (unlike ionchannels), hence the closest substitute to their native environment has been
assumed to be the cell membrane of eukaryotic cell lines like HEK293, Sf9, COS
and CHO cells. Cell-based assays, for example those measuring second
messenger levels, like cAMP, Ca2+ or IP3 in response to stimulation of a GPCR,
monitor signaling at very distal points but do not provide direct information about
the events going on more proximally; that is, at the G protein level. In fact, ligand
efficacies and potencies measured at the G protein level and at the effector level
in a given signaling cascade can be quite different (Seifert, Wenzel-Seifert et al.
1999). GPCR-dependent functions other than ligand-receptor binding might give
a signal that might be construed as an affirmative response to ligand binding.
These signals may be due to compounds acting on GPCRs like regulator of G
protein signaling-4 (RGS4), accessory proteins like receptor-activity-modifying
proteins (RAMPs), or receptor dimerization. Overexpression of the receptor can
lead to aberrant responses due to inappropriate stoichiometry of these proteins.
There may be a lack of reproducibility in-vivo, in particular regarding signaling
from cells transfected with high levels of a GPCR. Finally, it is entirely possible
that GPCR signaling in-vivo is influenced by its location within signaling
complexes that are cell-type specific (Steinberg and Brunton 2001; Luttrell and
Lefkowitz 2002). Cell based assays have the advantage that they can be adapted
in a relatively straightforward way for high throughput screening of compounds;
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by binding competition assays for instance. An alternative system for studying
ligand-receptor, or receptor-G protein phenomena will have to discard the
presence of ‘interfering’ players and phenomena mentioned above, while
maintaining the native-like lipid environment for the receptor and preserving the
advantages of simplicity and high-throughput screening. GPCRs, like most other
complex membrane proteins, are dependent on a lipid environment for structural
stability and integrity. The importance of a lipid environment is exemplified in
literature reports which exemplify profound effects of different membrane lipids
on functional parameters of rhodopsin (Botelho, Gibson et al. 2002; Botelho,
Huber et al. 2005). Furthermore, a lipid environment has been reported to
enhance G protein binding to the activated GPCR compared with detergents
(Melia, Malinski et al. 2000; Zhang, Melia et al. 2004).
Biophysical studies of GPCRs have been indispensable in providing
knowledge of ligand-dependent conformational states of a receptor (Imamoto,
Kataoka et al. 2000; Ghanouni 2001; Devanathan, Yao et al. 2004), intermediate
conformations adopted by the receptor upon activation (Palanche 2001;
Swaminath 2004) and receptor oligomerization (Bouvier 2001; George, O'Dowd
et al. 2002; Mercier, Salahpour et al. 2002; Fotiadis, Liang et al. 2004). The
majority of the biophysical studies on GPCRs have been done on receptors
solubilized in detergent micelles, reconstituted in lipid vesicles or overexpressed
on the cell surface. A monodisperse, soluble form of the receptor, although
convenient for in-vitro assays, does not usually provide a native environment of
the receptor and thereby makes an underestimation of the role of native membrane
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lipids in the modulation of GPCR function. Molecular assays that directly report
G protein activation and conformational changes undergone by the receptor in a
controlled lipid environment could bridge the gap between the limited information
obtained from simple binding assays in detergents and the complexity of cellbased systems.
A crystal structure provides a high-resolution snapshot of a single receptor
conformation, often with some artifactual elements. Although it gives a wealth of
information, x-ray crystallography alone is unlikely to be sufficient in elucidating
the dynamic picture of agonist binding, receptor oligomerization and G protein
interactions in the native state of the GPCR. The organization of GPCR systems
and signaling complexes is still an open question. Even in the case of rhodopsin,
the field is sharply divided on the question of whether it is dimeric in its native
membrane. Therefore, we developed the NABB system as a platform to study G
protein activation by either one (monomer) or two (putative dimer) rhodopsins
isolated and purified in a soluble lipid bilayer. We performed characterization
experiments, including electron microscopy imaging of the particles with one or
two rhodopsins and we proposed the relative limits of G protein activity of a
putative rhodopsin dimer with respect to that of the monomer. We also show that
our strategy of GPCR reconstitution may be applied to a different heterologously
expressed GPCR – called CCR5, and that CCR5 reconstituted in NABBs retain
their native conformation and G protein activity.
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2.0
Materials and Methods

2.1

Reagents and Buffers

Oligonucleotide primers were obtained from GeneLink (NJ), restriction
endonucleases from New England Biolabs (Ipswich, MA). Lipids were obtained
from Avanti Polar Lipids (Alabaster, AL). Detergents were obtained from
Anatrace Inc (Maumee, OH). Fluorescent dyes were obtained from Invitrogen
(Carlsbad, CA). All buffer reagents obtained from Sigma-Aldrich Inc. (St. Louis,
MO). Electron microscopy stains and grids were obtained from Electron
Microscopy Sciences (Hatfield, PA). All UV-visible absorption spectroscopy
experiments were performed in a Perkin-Elmer Lamda 800 UV-visible
spectrophotometer.
The following buffers were used in the methods followed in this project:
Buffer T: 25 mM Tris pH 8, 125 mM NaCl, 1 mM NaN3.
Buffer H1: 25 mM HEPES-MES-KOH pH 6.9, 125 mM KCl, 2 mM MnCl2,
2 mM CaCl2, 1 mM EDTA.
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Buffer H2: 10 mM HEPES-MES-KOH, 100 mM KCl. pH adjusted from 6.9 by
using either 1 N HCl (more acidic pH) or 1 N KOH (more basic).
Buffer N1: 20 mM Tris pH 7, 0.1 M (NH2)SO4, 10% glycerol, 0.07% CHS,
0.018% DOPC, 0.008% DOPS, 0.33% DM.
Buffer P1: 20 mM Tris pH 8, 1% (w/v) POPC, 0.01% (w/v) NBD-DPPE,
1% (w/v) CHAPS.
Buffer P2: 20 mM Tris pH 8, 0.6% (w/v) POPC, 0.4% POPS, 0.01% (w/v) NBDDPPE, 1% (w/v) CHAPS.
Buffer G1: 20 mM HEPES-MES-KOH pH 6.9, 0.3 M NaCl, 5 mM MgCl2,
5 μM GDP.
Buffer G2: 20 mM Tris pH 8, 0.3 M NaCl, 5 mM MgCl2, 5 μM GDP,
1 mM DTT.
Buffer GM1: 50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT.
Buffer GM2: 50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT, 1.2 M (NH4)2SO4,
25 μM GDP.
Buffer GM3: 50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT, 35% glycerol,
25 μM GDP.
Buffer R1: 30% (w/w) sucrose, 10 mM Tris-acetate pH 7.4, 130 mM NaCl,
0.4 mM MgCl2, 0.4 mM EDTA.
Buffer ISO: 20 mM Tris pH 7.1, 120 mM KCl, 60 mM NaCl, 10 mM MgSO4,
2 mM DTT, 0.1 mM PMSF.
Buffer HYPO: 5 mM Tris pH 7.1, 5 mM Mg(CH3COO)2.
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Buffer BG1: 10 mM sodium phosphate pH 6.5, 2 mM MgCl2, 0.1 mM EDTA,
1 mM DTT, 10% (w/v) glycerol.

2.2

Isolation and Purification of Rhodopsin

Rod Outer Segment (ROS) membranes were isolated from frozen darkadapted bovine retinae (W.L. Lawson Co., NE; Ph: 402-466-0492) using a
modification of previously reported procedure (Papermaster 1982). All steps were
carried out in the dark or under dim red light. Foil-wrapped vials containing 100
retinae were thawed in a water bath for 1 h. The retinae were placed in a dounce
homogenizer and flushed with Ar for 5 min. 60 mL of buffer R1 was added to the
retinae and the solution was homogenized 10 times very slowly with Ar flush
between the strokes. The retina solution was transferred to Ti-45 centrifuge tubes
(50mL per tube), flushed with Ar and centrifuged at 4k rpm, 20 min, 4°C. The
supernatant was collected and the pellet was re-homogenized by adding equal
volume of buffer R1 and applying 6-8 strokes of the homogenizer, and the
centrifugation repeated. The supernatants were combined in a beaker on ice and 2
volumes of 10 mM Tris-acetate pH 7.4 were added while stirring the solution
under Ar. The combined supernatants were centrifuged in a Ti-45 rotor at 7k, 50
min, 4°C. The pellet was preserved. A three-step sucrose gradient was prepared in
polyallomer centrifuge tubes for the Beckman SW-28 rotor. Sucrose densities of
1.15 g/mL (8mL), 1.13 g/mL (10mL) and 1.11 g/mL (10 mL) were used. 1.10
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g/mL sucrose solution was used to resuspend the ROS pellet in a total of 25mL
and this solution was distributed to bring the polyallomer tubes to final volume.
The tubes were flushed with Ar and the SW-28 rotor was centrifuged at 24k, 1 h,
4°C. The band at the interface of 1.11/1.13 g/mL sucrose was harvested (highest
purity of ROS). The collected bands were pooled and diluted with 2 volumes of
water and distributed to Ti-45 tubes, flushed with Ar and centrifuged at 25k, 30
min, 4°C. The pellet was washed with water and the centrifugation repeated
twice. After the final wash, the pellet was resuspended in 67 mM sodium
phosphate pH 7.0. The ROS was dispensed as 500μL aliquots and stored wrapped
in foil at –80°C. Using this protocol, approximately 45 mg of ROS was obtained
at 5.6 mg/mL rhodopsin at a A280/A500 ratio of 3.
To purify rhodopsin from ROS, a membrane aliquot was thawed and
solubilized with 2.5mL of 1.5% Octyl Glucoside (OG) containing buffer H1
(Solubilization buffer) for 2-3 hours at 4°C on a nutator. The solution was then
centrifuged in a Beckman Type 50 rotor at 34,000 rpm for 10 min at 4°C. The
supernatant was added to 1mL cross-linked ConA-sepharose beads and nutated
for 1 h at 4°C. The beads were washed with Solubilization buffer and elution was
done using 100mM -methyl mannoside in 1.5% OG containing buffer H1.
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2.3

Site-specific Labeling of Rhodopsin with Fluorophores

Fluorophore labeling of rhodopsin was done on ROS membranes with
fluorophores functionalized with a maleimide group. The ROS used had a
rhodopsin concentration of 187 μM and absorbance 280nm/500nm ratio of 2.0.
The labeling reactions were carried out in a dark room under dim red light. The
fluorophores were stored as a 22 mM stock in DMSO at –20°C. The optimal
fluorophore to rhodopsin ratio at the start of the labeling reaction was determined
experimentally for different fluorophores. Typically, three different molar ratios
of dye to rhodopsin were used- 1:1, 3:1, 9:1. Each labeling reaction had ROS
containing 1.2 mg rhodopsin (163μL aliquot of the ROS) in 0.6mL tubes. After
addition of the appropriate volume of fluorophore stock, the tubes were flushed
with Ar and incubated for 12.5 h at 28°C with shaking in a thermomixer. The
reaction was terminated by adding 5 mM DTT to each tube and incubating on ice
for 10-15 min. The excess label was washed from the ROS using three washes of
1% BSA containing buffer H1. The ROS was then transferred to a 15mL tube
containing 2mL of 1.5% OG containing buffer H1 (Solubilization buffer) and kept
on a nutator for 1 h at 4°C. The solution was then transferred to centrifuge tubes
and centrifuged in a Beckman Type 50 rotor at 34,000 rpm for 10 min at 4°C. The
supernatant was added to 1mL cross-linked ConA-sepharose beads and nutated
for 1 h at 4°C. The beads were washed with Solubilization buffer 4-5 times, or till
coincident UV-vis spectra were obtained from subsequent washes. The rho was
eluted from the ConA beads using 100mM -methyl mannoside in 1.5% OG
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containing buffer H1, then pooled and concentrated using a centrifugal
concentrator with 10k MWCO. The final rho concentration was determined by
UV-vis difference spectral scan from 700nm to 250nm before and after
photobleaching the sample with yellow light. The stoichiometry of labeling was
determined by comparing the molar concentration of label and rho in the cuvette.
Site-specificity of labeling at a single accessible cysteine was confirmed
by digestion of labeled rhodopsin by V8 protease (Farrens, Altenbach et al. 1996)
and detecting labeled fragments on SDS-PAGE. V8 protease was added to rho in
1.5% OG buffer H1 at a molar ratio of 1:30. The mixture was incubated for 1.5 h
at 30°C and the fractions were analyzed by SDS-PAGE. The fluorescence in the
lanes of the gel was detected by a Typhoon 9400 imager (GE Healthcare) and the
gel was subsequently stained with Coomassie Blue to detect protein bands.

2.4

Labeling of Rhodopsin with Nanogold

Nanogold labeling of rhodopsin was also performed on ROS membranes
using monomaleimido nanogold (Nanoprobes, Yaphank, NY) using manufacturer
recommended

conditions

and

concentrations.

A

9:1

(M/M)

ratio

of

monomaleimido nanogold to rhodopsin was used, with 2.5mg of rho in ROS. The
mixture was incubated at 28°C for 16 h without shaking. The labeled rhodopsin
was purified as described in Method 2.3. The labeling stoichiometry was
determined by comparing the characteristic absorbance of nanogold at 420nm
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with rhodopsin absorbance at 500nm determined by UV-vis difference
spectroscopy and was found to be 0.8-0.9 (M/M) Nanogold/rhodopsin.

2.5

Isolation and Purification of Holotransducin

Frozen, dark-adapted bovine retinae (200 retinae in vials) were thawed in
a room temperature water bath for 30 min. 100mL cold ISO buffer was added
with protease inhibitors and stirred on an ice-bath for 30 min. The slurry was
filtered through a metal filter in batches. The volume was increased to 200mL
with ISO buffer. The solution was layered onto a 37% (w/w) sucrose cushion in
centrifuge tubes for a Beckman SW-28 rotor. Each tube contained 13mL of 37%
sucrose and 25mL retina slurry. The tubes were centrifuged in a SW-28 rotor at
22k rpm, 25 min, accel/decel 6/6 at 4°C. The tubes were opened in the dark room
and black bands at the interface of the sucrose and slurry were collected with an
18G needle and 10mL syringes. The volume of the collected bands was increased
to 250mL using cold ISO buffer. The sucrose cushion step was repeated and the
band at the same location of the tube was collected. Cold ISO buffer was added to
increase the volume of the collected bands to 200mL. The solution was
distributed in Ti-45 centrifuge tubes. The solution was centrifuged for 28k rpm,
20 min, 4°C. The reddish-orange pellet was resuspended in 200mL total ISO
buffer using a dounce homogenizer. The slurry was transferred to a beaker kept
on ice and illuminated from below with >495nm light with constant stirring for 20
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min. The illuminated slurry was distributed into Ti-45 tubes (50mL per tube) and
centrifuged at 30k, 20 min, 4°C. The pellet was then resuspended in HYPO buffer
and homogenized using the dounce homogenizer. The centrifugation and
homogenization steps were repeated with increasing centrifugation speeds each
time- 32k, 36k, 40k for 20 min, 4°C. Holotransducin (Gt) was extracted from the
ROS membranes by adding 200 μM GTP containing HYPO buffer and incubating
on ice for 10 min. The slurry was centrifuged at 42k, 20 min, 4°C and the
supernatant was collected. The total volume of the extractions was kept under
150mL. The pooled GTP extractions were centrifuged at 42k, 20 min, 4°C to
remove any residual membranes. The extract was then loaded on a hexylagarose
column (25mL hexylagarose packed in a GE Healthcare XK 16/20 column) at
0.25mL/min at 4°C equilibrated with HYPO buffer. The hexylagarose column
was washed sequentially with HYPO buffer, 75 mM NaCl containing HYPO
buffer. The Gt was eluted with a step of 300 mM NaCl in HYPO. The peak
fractions were pooled and dialyzed against Gt storage buffer (20 mM Tris pH 7.1,
2 mM MgSO4, 1 mM DTT, 5 μM GDP, 10% glycerol). The dialyzed product was
distributed as 200μL aliquots, flash-frozen in liquid N2 and stored at –80°C till
further use. A concentration of 15 μM Gt, and approximately 7-9mg Gt was
obtained from 200 retinae using this protocol.
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Isolation of  subunits from Holotransducin

2.6

Holotransducin (Gt) stock containing 1 mg of Gt was thawed and diluted
1:4 in buffer BG1. The sample was applied to a 1mL Blue Sepharose column (GE
Healthcare) using an Akta Exlorer 10 FLPC system. The column was washed
with 5 column volumes using buffer BG1 and eluted with a linear gradient of
buffer BG1 containing 2 M NaCl. The  subunits elute first, followed by the Gt
subunit. The proteins were identified on the basis of molecular weight using SDSPAGE.

2.7

Site-directed Mutagenesis of Gi1 DNA

Multiple site-directed mutagenesis reactions were performed on the
pET-28a(+) Gi1 DNA using the components and parameters specified in the
QuikChange Multi Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). Six
cysteine residues were chosen to be modified such that four single-cysteine
containing Gi1 DNA would be produced, each construct containing a Cys at a
distinct, known position in the sequence- C66, C214, C305, C325. The following
amino-acid mutations and corresponding DNA primers were used for the
mutagenesis, with the specific codon change underlined:
(1) C3S- ggctagcatgggctccacactgagcgctgaggac
(2) C66A- gctggctactcagaggaagaggctaagcagtacaaagcagtg
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(3) C214S- cggaagaagtggattcacagctttgaaggcgtgactgcc
(4) C305S- ggcggctgcgtatatccagagccagtttgaagacctc
(5) C325A- cacccacttcactgccgccacggatacgaagaatgtg
(6) C351I- gaataacctaaaagacattggtctcttctaagaattcgagctcc
100ng of template DNA was mixed with 100ng of each primer. Only antisense primers were added. The 10x reaction buffer, dNTP mix and QuikChange
Multi Enzyme blend were mixed in de-ionized water was added to make a final
reaction volume of 25μL. The thermal cycler was programmed to run the
following temperature and time cycles- (1) 1x 95°C, 1 min; (2) 30x 95°C, 1 min;
55°C, 1 min; 68°C 13 min; (3) 1x 4°C, overnight. At the end of the PCR reaction,
the mixture was treated with 1μL of Dpn-I restriction endonuclease and incubated
at 37°C for 1 h. The Dpn-I treated product was transformed into XL-10 Gold
E. coli cells according to the manufacturer’s protocol. The cells were plated on an
LB-agar plate containing 50μg/mL Kanamycin (Kan) and incubated overnight at
37°C. 8-12 single colonies were picked and re-streaked on a fresh Kan plate and
sent for sequencing to Genewiz (NJ). The Multi-site QuikChange reaction was
repeated twice in order to obtain all the desired Cys mutations of the DNA.
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2.8

Purification of Recombinant Gi proteins

2.8.1 Hi-yield Heterologous Expression of Gi1

BL21(DE3) E. coli cells were transformed with pET28a(+) Gi1 construct
with C66 as the accessible cysteine (see section 2.6). A single colony was isolated
from LB-Kan agar plates and introduced into 250mL LB-Kan media, and the
culture was grown overnight at 37°C with shaking at 250rpm in an incubator. The
starter culture was diluted 1:100 into 1.6 L of sterilized LB-Kan media, incubated
at 37°C with shaking at 180rpm and induced with 0.5mM isopropyl--Dthiogalactopyranoside (IPTG) at OD600 of 0.5-0.6. The temperature was decreased
to 30°C and the cells were harvested after for 16 hours. The cell pellet was
resuspended in storage buffer (40 mM Tris pH 8, 0.3 M NaCl, 2 mM PMSF,
5 mM 2-mercaptoethanol, 1x Aprotinin and Complete EDTA-free protease
inhibitor tablets) and stored at –80oC until further use.

2.8.2 Site-specific Labeling and Purification of C66 Gi1

E. coli cells were thawed and lysed using a French Press. The lysate was
centrifuged at 30,000xg, 45 min, 4°C. The supernatant was clarified by passing
through a 0.45μm syringe filter. 2mL of Ni-Sepharose 6 FF slurry (GE
Healthcare)

equilibrated

with

20

mM Tris pH

8,

150

mM NaCl,

2 mM 2-mercaptoethanol was added to the reaction mixture alongwith
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20 mM imidazole and incubated for 2-3 h at 4°C. The solution was centrifuged
and the resin was washed with 10 volumes of buffer G1 containing 20 mM
imidazole. The resin was transferred to a 2mL eppendorf tube and 0.3 mM
Alexa-546 maleimide was added in 1mL of slurry. The tube was flushed with Ar,
wrapped in foil and kept nutating overnight at 4°C. The slurry was transferred to a
15mL tube and was washed thrice with buffer G1 containing 1 mM DTT. The
protein was eluted thrice with 300 mM imidazole. The eluate was concentrated to
approximately 2.5mL using a Centricon centrifugal concentrator with 10 kD
MWCO. 0.5mL of GST-tagged PreScission protease was added, and the solution
was dialyzed overnight at 4°C in a 3mL Slide-A-Lyzer dialysis cassette (Pierce)
against 1000-fold excess of buffer G2. The dialyzed mixture was loaded on a 1mL
Ni Sepharose 6 FF column (GE Healthcare) and the flowthrough collected, which
now contained the cleaved, labeled Gi1. The Ni column flowthrough was applied
to a GST-Sepharose column and the flowthrough collected. GST-tagged
PreScission protease was removed from Gi1 at this stage. The GST column
flowthrough was finally applied to a Superdex 200 10/300 gel-filtration column,
and the fractions analyzed by SDS-PAGE. Using the above protocol, a
stoichiometry of 1:10 label to Gi1 was obtained.

2.8.3 Expression and Purification of N-myristoylated Gi1

DNA

plasmids

coding

for

Gi1

(pQE60-Gi1)

and

yeast

N-

myristoyltransferase 1 (NMT1) enzyme (pBB131-NMT1) were a kind gift of Dr.
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Maurine Linder and were used to express N-myristoylated Gi1 (Duronio,
Jackson-Machelski et al. 1990). Yeast NMT1 has been shown to cotranslationally myristoylate G-protein -subunits, including Gi1 (Greentree and
Linder 2004). The two plasmids were incorporated into BL21(DE3) strain of E.
coli by heat-shock transformation. pQE60-Gi1 had the Amp resistance marker
and pBB131-NMT1 had the Kan resistance marker; therefore both Ampicilin and
Kanamycin were used at 50μg/mL each in the LB-agar plates and media. The
starter cultures and media were prepared similar to Method 2.7.1. The cells were
grown in LB-Kan-Amp for approx. 3 h at 37°C until the OD600 reached 0.6–0.8.
The culture was induced with 0.25 mM IPTG and grown at 30°C, 16 h, with
180rpm shaking. The cells were harvested and stored in 40 mM Tris pH 8,
1 mM PMSF, 1x protease inhibitor cocktail mix (note: no NaCl was used since
NaCl would interfere with subsequent purification steps) and frozen in liquid N2.
The cell pellet was thawed and lysed using a French Press. 0.5 mM
DNase-I and 5 mM MgSO4 was added and the mixture incubated for 30 min at
4°C. The solution was centrifuged for 30 min, 30,000xg, 4°C. The supernatant
was added to 15mL DEAE resin equilibrated with buffer GM1. The slurry was
incubated for 30 min at 4°C. The slurry was then poured onto a 0.22μm filter
attached to a Buchner funnel and vacuum line and washed with 100-200mL of
buffer GM1 under vacuum. The protein was eluted thrice with 40mL buffer GM1
containing 300 mM NaCl under vacuum and collected. Ammonium sulfate was
added from a 3.6 M stock to make 1.2 M in the solution containing the DEAE
eluate. This was loaded on a 25mL Phenyl Sepharose (PS) column (GE
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Healthcare) pre-equilibrated with buffer GM2 using an Akta Explorer 10 FPLC
system. The bound proteins were eluted by a decreasing linear gradient of
ammonium sulfate (buffer GM2) and using buffer GM3 as the elution buffer. The
peaks were assayed for Gi1 presence by using small aliquots and observing Trp
fluorescence increase upon addition of aluminium fluoride (Phillips and Cerione
1988) in a SPEX fluorolog instrument. The final eluted peak is assumed to be
myristoylated Gi1 based on its higher hydrophobicity and AlF4- mediated
increase in Trp fluorescence signal. The peak was applied to a desalting column
equilibrated with buffer GM1 containg 25 μM GDP. The desalted product was
applied to a 1mL MonoQ column equilibrated with buffer GM1 and eluted with a
linear gradient of NaCl. The eluted peaks were assayed for GDP binding by AlF4and the relevant peak was collected and applied to a Superdex 200 gel-filtration
column. The peaks eluted from the column were analyzed using SDS-PAGE and
stored at –80°C until use.

2.9

Amino Acid Alignment of Zebrafish and Human Apo A-I

Amino acid sequences of Danio rerio apolipoprotein A-I (NCBI accession
number: NP_571203) and Homo sapiens apolipoprotein A-I preproprotein (NCBI
accession number: NP_000030) were downloaded from NCBI in FASTA format
for analysis. The first 21 amino acids from the N-terminus of Danio rerio apo A-I
sequence and the first 24 amino acids from the N-terminus of Homo sapiens apo
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A-I preproprotein sequence were discarded from the analysis (and subsequent
constructs) as putative hydrophobic or signal sequences. The sequences were
aligned using ClustalW (http://www.ebi.ac.uk/clustalw/) and the amino acids
were color coded to highlight different levels of similarity.

2.10

Determination of Salt-Bridging Score in Apo A-I

Salt-bridging analysis, and helical net representations were done
computationally using the ALIGN and WHEEL software programs (Jones,
Anantharamaiah et al. 1992; Segrest, Jones et al. 1999) kindly provided to us by
Jere Segrest from the University of Alabama Medical Center (Birmingham, AL).
The software was installed, compiled and run on a SGI Octane machine (Silicon
Graphics Inc., Sunnyvale, CA).
ALIGN uses an algorithm to sum a weighted score of salt-bridges and
charge appositions for each helix-helix docking position of the three possible
interfacial orientations of apo A-I. Salt-bridges and charge appositions are
determined in the software by taking a helical net representation of the protein
helix (Jones, Anantharamaiah et al. 1992) arranged as an 11/3 helix monomer
and inverting and superimposing its L or R interface onto the L or R interface of a
second monomer beginning with a complete overlap between them. Interactions
were controlled by distance between residues down the helix axis, by radial
distance between residues and by radial distance of their average position from
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the polar-nonpolar interface. Salt-bridges are assigned a score of -1, and like
charge appositions a score of +1, weighted by a sliding scale reflecting the
average position of the residue relative to the interface of the polar-nonpolar
faces. The 2 helical nets were translated relative to each other, one residue at a
time, in a closed loop fashion.
Helical net representations were obtained using the HELNET program
which was part of the WHEEL software suite. This program creates a diagram of
the  helix seen as a cylinder cut along the center of the polar face and flattened.
The center of the hydrophobic face (determined by the hydrophobic moment) lies
in the center of the figure and is oriented to rise out of the page.

2.11 Cloning of apo A-I DNA Plasmids

Danio rerio apolipoprotein A-I cDNA was generated by reverse
transcriptase PCR from 1μg of D. rerio total RNA using the primers
5’-CAGGCTGATGCCCCGAC-3’ corresponding to N-terminus of the translated
protein and 5’-TTATGCCTGGATGGCCTTGG-3’ corresponding to the Cterminus. Restriction sequences for NheI and HindIII were incorporated in the
primer sequence upstream of the apolipoprotein cDNA sequences. RT-PCR was
performed using a one-step RT-PCR kit (cMaster RT plus PCR system,
Eppendorf). The cDNA obtained was cloned into the TOPO cloning vector
(Invitrogen) and the sequence confirmed. The cDNA was then cut by NheI and

48

HindIII restriction endonucleases and ligated into pET28a(+) vector (Stratagene)
to give the vector pE28-ZAP1. To incorporate a site-specific cysteine, a single
Gln residue near the N-terminus was mutated to Cys (Q26C) by site-directed
mutagenesis of pE28-ZAP1 to yield pE28-ZAP1Q26C.
Human apo A-I clone was obtained from ATCC (MGC-12499) and cloned
into a pET16a vector (Stratagene) which was altered to have a N-terminal hexahistidine purification tag to give the vector pE16-HAP1. All nucleotide sequences
were confirmed by DNA sequencing (Genewiz, South Plainfield, NJ).

2.12 Purification of His-tagged Apo A-I

The vector was transformed into BL21(DE3) Rosetta2 strain of E. coli and
colonies were streak-purified on Kanamycin and Chloramphenicol containing LBagar plates. A single colony was grown in 250mL LB media containing 50μg/mL
of both kanamycin and chloramphenicol overnight at 37oC with shaking and
called the starter culture. The starter culture was diluted 1:100 into 1.6 L of
sterilized TB media, incubated at 37oC with shaking at 180rpm and induced with
1 mM isopropyl--D-thiogalactopyranoside (IPTG) at OD600 of 0.5–0.6. The cells
were harvested after for 3-4 hours. The cell pellet was resuspended in storage
buffer (40 mM Tris pH 8, 0.3 M NaCl, 2 mM PMSF, 5 mM 2-mercaptoethanol,
1x Aprotinin and Complete EDTA-free protease inhibitor tablets) and stored at
–80oC until further use.

49

The cell pellet was thawed and the cells disrupted by a French press. Solid
guanidinum chloride was added to make the 6M concentration in the cell lysate.
The lysate was incubated at room temperature for 30 minutes, then centrifuged at
>25,000xg for 1 hour. The supernatant was filtered through a 0.45μm filter and
loaded onto a Ni-Sepharose 6 FF column (GE Healthcare) pre-equilibrated with
Buffer T containing 6 M Gn.HCl, 25 mM imidazole at pH 8. The column was
washed sequentially with 2CV 6 M Gn.HCl containing buffer, 2CV 2 M Gn.HCl
buffer and finally 5CV of Gn.HCl free Buffer T containing 25 mM imidazole.
The protein was eluted by an imidazole gradient and the elution followed by
monitoring OD at 280nm on an Akta Explorer 10 FPLC system. Maximum
elution occurred at 250–300 mM imidazole. Gel-filtration chromatography was
performed by pooling the zap1 containing fractions and running on a Superdex
200 26/60 column (GE Healthcare) and eluting with buffer T with 1 mM TCEP.
The peaks were assayed for purity by SDS-PAGE. The pure protein was termed
6xHis-zap1.

2.13 Site-specific Labeling of 6xHis-zap1Q26C

A novel on-column approach was used to facilely label the zapIQ26C
mutant with Alexa-488 maleimide. A 1mL Ni-Sepharose 6 FF column was used
for labeling the Cys mutant. The fluorophore was made upto 0.2 mM in Buffer T
containing 2 M Gn.HCl at pH 7.4 from a 22 mM fluorophore stock in DMSO.
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After the binding zapIQ26C to the column and washing with Buffer T with 6 M
Gn.HCl at pH 7.4, the fluorophore was introduced with a syringe and the
flowthrough was passed over the column again. The column was then washed
with 4CV of Buffer T containing 2 M Gn.HCl and finally 5CV of Gn.HCl free
buffer containing 25 mM imidazole. The protein was eluted by introducing a 300
mM imidazole solution in buffer T pH 7.4 by a syringe. The collected fraction
was subjected to gel-filtration on a Superdex 200 10/30 column and eluted with
buffer T with 1 mM TCEP. The peaks were assayed for purity and the labeling
ratio was determined by comparing OD488 and OD280. A 1:1 ratio of Alexa-488
to zap1 was obtained under the above conditions.

2.14 Preparation of Labeled Lipids

POPC was weighed from lyophilized stock and dissolved in 1% sodium
cholate containing buffer H1 to make a 1% POPC solution. The solution was
subjected to several freeze cycles in liquid nitrogen followed by vortexing at room
temperature to get a clear solution. In order to make a labeled lipid stock,
lissamine rhodamine B-sulfonyl labeled DOPE was dried from a 2mg/mL CHCl3
stock vial in a glass round bottom flask under Ar gas. The flask was put under
high vacuum overnight to remove traces of CHCl3. The flask was weighed and the
amount of dry labeled DOPE was calculated. The dried DOPE was dissolved in
1% cholate containing buffer H1 to make a 1mg/mL solution. A part of the POPC
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stock was doped at 1% (w/w) of lissamine rhodamine B sulfonyl and this was
taken to be the labeled lipid stock.

2.15 Self-assembly of NABBs and Rhodopsin-NABBs

The NABB formation with or without rhodopsin incorporated is a selfassembly process triggered on detergent removal after mixing and incubating the
NABB components. A molar ratio of 150 POPC : 2 zap1 in 1.5% (w/w) sodium
cholate and 1.5% OG containing buffer T was taken to form an ‘empty’ NABB.
For each rhodopsin to be incorporated, 34 POPC were subtracted from the initial
reaction mixture based on previous reports of area occupied by a rhodopsin
molecule in a POPC bilayer (Huber, Botelho et al. 2004). Detergent removal was
accomplished either by dialyzing the samples using Slide-A-Lyzers (Pierce
Biotechnology, Rockford IL) of appropriate volume against 1000x excess volume
of detergent free buffer for 36 hours with 2-3 buffer exchanges or by loading the
reaction mixtures onto pre-equilibrated Extracti Gel D (Pierce Biotechnology,
Rockford IL) columns typically of 1mL volume, made by loading Extracti Gel D
slurry into cleaned Sep-Pak columns (Waters). In the case of Extracti Gel D
reconstitutions, typically 200μL of the detergent containing initial reaction
mixture was layered on top of the packed 1.5mL resin. The solution was allowed
to completely enter the column and then eluted by adding 200μL of detergent free
buffer on top and collecting equal volume of eluate fractions in 1.5mL eppendorf
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tubes till 1mL of the detergent free buffer has been added to the column. The
NABBs eluted over 2-3 fractions, as determined by UV-vis spectroscopy.
Removal of bile-salt based detergents by both dialysis and the rapid extracti gel D
reconstitution was quantitated by using a 3--steroid dehydrogenase enzyme
assay using a total bile-acid assay kit (Diazyme, San Diego, CA) calibrated with
either cholate or CHAPS and POPC. No significant traces of detergents were
found after the reconstitutions. Once formed, the rho-NABBs were purified by
gel-filtration chromatography on a Superose 6 10/30 column using an Akta
Explorer 10 FPLC system (GE Healthcare, Piscataway, NJ) used within 1-2 days
for the various assays. All of the above steps were carried out under dim red light
to keep rhodopsin in its dark state.
Direct incorporation of rhodopsin from ROS into NABBs was done taking
a molar stoichiometry of 1 rho per 100 NABBs. Typically, ROS containing
0.5 μM rhodopsin was taken in a 200 μL aliquot containing 100 μM 6xHis-zap1,
7.5 mM POPC, 1% DM, Buffer H2 with 2 mM MgCl2 and 1 mM CaCl2. The
mixture was vortexed, centrifuged and loaded onto pre-equilibrated 1.5 mL
Extracti Gel D columns, and eluted using detergent free buffer.

2.16 FRET Measurements between Rhodopsins

Fluorescence resonance energy transfer (FRET) measurements were made
in a SPEX Fluorolog tau-3 spectrofluorimeter, equipped with a 450 W Xenon arc-
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lamp and single grating excitation monochromator, set to 0.26nm bandpass and
the single grating emission monochromator, set to 5nm bandpass. The signal was
integrated for 2 seconds. Data was recorded for 1 h in 30 seconds intervals to
account for any changes in the signal due to bleaching of rhodopsin from dark to
light state by the excitation beam. The excitation shutter was closed in between
acquisitions to minimize photobleaching. The temperature of the cuvette holder
was maintained at 20°C by a circulating water bath. The concentration of
rhodopsin in NABBs or vesicles was kept at 10 nM in the cuvette with 250μL
buffer H1 for all experiments. The experiment was started after 10 min incubation
of the rho sample in the cuvette at 20°C. The excitation and emission wavelength
pairs (in nm) used on the instrument were- (1) Donor (Alexa-546) channel: Ex=
558, Em= 570; (2) FRET (Alexa-546 to Alexa-647) channel: Ex= 558, Em= 670;
(3) Acceptor (Alexa-647) channel: Ex= 655, Em= 670. After 1 h of data
acquisition, dodecyl maltoside (DM) was added from a 20% stock to make 1.5%
in the cuvette and the solution was mixed. The data acquisition was continued.
Finally, hydroxylamine was added from a 3.5 M stock to obtain 50mM in the
cuvette, and the sample bleached using >495nm light and the spectrum was taken
of the sample in a detergent solubilized, bleached state. The detergent solubilized
rho reading was considered as the internal control for the respective samples and
the spectra were normalized using this control. The data right before detergent
addition was taken for analyzing the FRET index.
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2.17 Decoration of Rhodopsin in NABBs by Fab Fragments

Fab fragments from the monoclonal antibody 1D4 were generated by
proteolytic cleavage of 1D4 by Papain, followed by gel-filtration chromatography
on a Superdex 200 10/300 column. Purity of the Fab fraction was checked by
SDS-PAGE and concentration determined by absorbance at 280nm. Fab
fragments were incubated at equimolar ratio to the rhodopsin in NABBs with
gentle nutation in the presence of Concanavalin A–Sepaharose beads (Sigma)
overnight at 4°C. The beads were washed three times with buffer and then the
Fab-rho-NABB complex was eluted thrice using 100mM -methyl mannoside
containing elution buffer. The elutions were concentrated using an Amicon-15
centrifugation filtration device with a 50kD MWCO and the buffer was
exchanged simultaneously with -methyl mannoside free buffer. The complex
was then subjected to gel-filtration chromatography over a Superose 6 10/30
column (GE Healthcare) and the peak fractions were used for EM analysis.

2.18

Negative-stain Transmission Electron Microscopy

5μL of freshly prepared NABB sample at a protein concentration of
approximately 5-10 μg/mL was applied on a 400 mesh carbon coated copper grid
which had been glow discharged for 10-20 seconds prior to sample application.
The NABB solution was blotted after 1 minute and an equal volume of 1% uranyl
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acetate was added immediately. The stain was gently wicked away and the
staining repeated again. The grids were then imaged under 80keV using a Jeol
1230 transmission electron microscope equipped with a 1Kx1K CCD camera.
Images were acquired typically at 1-2 μm underfocus to obtain optimal contrast.
Nanogold images were acquired at regions of sparse stain and at lower defocus
(200-500nm) in order to achieve highest density and contrast of the gold clusters
(Hainfeld, Powell et al. 2002).

2.19 Circular Dichroism (CD) Spectroscopy and Isothermal
Titration Calorimetry (ITC)

CD spectra were recorded at 25°C in an AVIV 202 circular dichroism
spectropolarimeter. Typically, 22 μL of apo A-I sample at 1.1 mg/mL was
incubated with 100 μL of POPC at 1.5 mg/mL in the form of Small Unilamellar
Vesicles formed by sonication. Tris salt buffer (50 mM Tris pH 7.6, 150 mM
NaCl) was added to a final volume of 400 μL. The sample was vortexed
immediately and loading into a 0.1 cm path length cuvette and scanned from
250nm to 190nm with 0.5nm resolution and 1nm bandwidth. The temperature was
kept constant with a circulating water bath. Raw ellipticity values were converted
to Molar Residue Ellipticity for comparison of spectra between peptides and
proteins of varying lengths and concentrations. Ellipticity values in millidegrees
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from the AVIV CD software was converted to Molar Residue Ellipticity using the
equation:

Molar Residue Ellipticity [] =

millidegrees
# a.acids  conc(M ) pathlength(cm)10

The fraction alpha helicity was calculated from Molar Residue Ellipticity
at 222nm according the following equation (Wieprecht, Beyermann et al. 2002):
[]obs[ ]coil
f h = []helix[
]coil

[] values for the alpha helical and coil parts are derived from:
[]helix = -40000(1 – 2.5/n) + 100t, []coil = 640 – 45t,
where n is the number of amino acids in the protein (n for zap1 is 266 and
for hap1 it is 222) and t is the temperature in °C.
Isothermal Titration Calorimetry experiments were performed in the VPITC high-sensitivity titration calorimeter (MicroCal, MA). Typically, 20
consecutive injections of 10 μL aliquots of the apolipoproteins from a stock
concentration of 60 μM were made into 2 mM POPC Small Unilamellar Vesicles
in the sample cell. The protein and POPC SUVs were dialyzed against the same
buffer prior to the experiment and both lipid and protein solutions were degassed
under vacuum immediately before use. Injections were made at intervals of 15
min, the duration of each injection was 2 s/μL and a constant stirring speed of
400rpm was maintained throughout the experiment to ensure proper mixing. The
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ITC cell temperature was kept at 30oC. Data were analyzed using the Origin
software provided by MicroCal Inc.
The experimental data were fitted to a curve corresponding to a Langmuir
adsorption model of a single class of binding sites to obtain the equilibrium
association constant (Ka), the enthalpy change (Ho) and the stoichiometry
parameter (N, the number of protein molecules bound per lipid molecule). The
areas under the negative peaks corresponded to the heat released during the
reaction after the addition of the protein to the SUVs. The values of Ka and Ho
obtained from curve fitting were used to calculate the standard free energy change
(Go) and the standard entropy change (So) for the binding using the equation:
G° = – RT ln Ka = H° – TS°
We use a modified standard state with respect to the experimental
temperature of 30°C.

2.20 Thermal Stability Assay of Rhodopsin

Rho-NABBs were formed by dialysis, followed by Ni affinity purification
in the dark. Aliquots of 1 μM rhodopsin in NABBs or ROS or detergent
containing buffer H1 were incubated in 0.6mL eppendorf tubes at various
temperatures in a thermomixer without shaking. After 15 minutes of incubation,
each aliquot was kept on ice till it was used for a UV-visible scan in a PerkinElmer Lambda 800 UV-visible spectrophotometer at room temperature. The
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sample was then photobleached under yellow light (>495nm wavelength) for 30
seconds in the presence of 50 mM hydroxylamine. The intact rhodopsin content
of the sample was estimated by calculating the difference in absorption intensity
between the dark and light spectra at 500nm. The absorption was expressed as the
fraction of absorption of a sample stored at 4oC and plotted as a function of
temperature.

2.21 Rhodopsin Meta-II Decay Assay

Decay of rhodopsin Meta-II state in NABBs was followed by tryptophan
fluorescence. Rhodopsin concentration was adjusted to 10nM in 10 mM HEPESMES-KOH buffer pH 6, 100 mM KCl, 2 mM MgCl2 in a magnetically stirred
cuvette. The temperature was maintained at 20°C by a circulating water bath
attached to the cuvette holder. Tryptophan fluorescence was recorded in a SPEX
Fluorolog tau-3 spectrofluorimeter, equipped with a 450 W Xenon arc-lamp and
single grating excitation monochromator, set to a center wavelength of 295nm
with 0.2nm bandpass. A UV-bandpass filter (Hoya U-340, Edmund Optics, Inc.,
Barrington, NJ) was used in addition to the single grating emission
monochromator, set to 330nm and 10nm bandpass. The signal of the photoncounting photomultiplier was integrated for 2 seconds. Data was recorded for two
hours in 30 seconds intervals with the excitation shutter closed in between
acquisitions to minimize photobleaching, unless stated otherwise. The rhodopsin
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sample in the cuvette was bleached for 15 sec using a fiber-optics 150 W
illuminator at full intensity with a yellow filter (model A-200, Dolan-Jenner
Industries, Inc., Boxborough, MA) after obtaining a dark baseline for 3 minutes.
The decay of the photolyzed state was followed for 2 hours.

2.22 Regeneration of Opsin in NABBs

Opsin-NABBs were generated by photobleaching 1 μ of 1 rho-NABB in
buffer H2 pH 6 for 1 minute and incubating the photobleached sample at room
temperature for more than 2 hours. A UV-vis scan was done every 10 minutes to
ensure the lack of any significant absorbance at 480-550nm region. The sample
was compared with a control containing 50 mM NH2OH. 11-cis-retinal was
solubilized from a 2 mM ethanolic stock upto 100 μM in approximately 1μM
empty NABBs and vortexed vigorously to ensure proper mixing. Concentration of
11-cis-retinal was determined by its absorption peak at 378nm and using a molar
extinction coefficient of 24940 M-1 cm-1. Under dim light, 11-cis-retinal loaded
NABBs were gently added by a microcapillary pipette tip to a final concentration
of 0.5 μM 11-cis-retinal to a stirred microcuvette containing 700μL of 0.5 μM
opsin-NABBs. Absorbance was monitored at 520nm, with a slit width of 0.5nm,
integration time of 1 sec and time interval of 3 seconds. After saturation of the
absorbance signal, 50 mM of NH2OH was gently added from a 3.5 M NH2OH
stock. Finally, the sample was bleached using hi yellow light.
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2.23 Transducin Activation Assay using Intrinsic Trp
Fluorescence

1 rho-NABB sample was purified by 1D4 affinity purification of the
dialysis product of a starting ratio of 0.1 rho/NABB to remove ‘empty’ NABBs
from interfering in the assay. Following 1D4 affinity, both 1 rho-NABB and 2
rho-NABB samples were subjected to FPLC purification in the dark. Activation
of holotransducin by rhodopsin incorporated in NABBs was analyzed by the
tryptophan fluorescence assay (Fahmy and Sakmar 1993). Typically, 10 nM of
rhodopsin-NABBs was added to 100 nM holotransducin in 10 mM HEPES-MESKOH buffer pH6.9, 100 mM KCl, 2 mM MgCl2 in a continuously stirred cuvette
thermostatted at 10°C in a SPEX Fluorolog-II spectrofluorimeter. The sample
was excited at 300nm with 2nm slit width and emission was recorded at 340nm
with a 12nm slit width. GTP-S was added to a final concentration of 5 M in the
cuvette. The cuvette was then illuminated by 543nm light from a HeNe laser and
the spectra was collected under constant illumination to photoactivate rhodopsin.
The curve obtained was analyzed by fitting an exponential corresponding to a
pseudo-first order kinetics.
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2.24 Isolation of Heterologously Expressed CCR5 Receptor and
Incorporation in NABBs

HEK-293 cells stably expressing CCR5 were harvested and the cell pellet
stored in PBS buffer containing protease inhibitors at –80°C. Cell pellets
corresponding to 2 x 10 cm plates were thawed on ice and lysed using 500mL of
buffer N1. The solution was sonicated using a probe-tip sonicator for 6 x 1 s
pulses with 10 s cooling on ice. The tube was then incubated at 4°C with gentle
mixing for 30 min. The tube was centrifuged at 20,000xg for 20 min at 4°C. The
supernatant was collected and applied to 50mL of 1D4-sepharose slurry loaded
with 2mg/mL of 1D4 and the mixture incubated at 4°C with gentle mixing for 30
min. The resin was centrifuged and washed with 500mL of buffer P2. The 1D4
bound protein was eluted by adding 50mL of buffer P2 containing 1D5nonapeptide. Zap1 was added to the eluate at a final concentration of 80 μM. The
mixture was vortexed, incubated on ice for 30 min and applied to a preequilibrated 500mL Extracti Gel–D column at 4°C. Elution was carried out under
gravity flow by addition of detergent free buffer to the column and collecting
50mL fractions. The fractions were analyzed for protein elution by monitoring
absorbance at 280nm.
The protein containing fractions were pooled and applied to a Superose 6
PC 3.2/30 gel-filtration column. The eluted peaks corresponding to the NABB
elution were applied to 50μL of 1D4-sepharose. The resin was washed with buffer
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P2 and eluted with 1D5 containing buffer P2. Aliquots from different stages of
this protocol were used to assay for CCR5 using ELISA or western blots.

2.25 Sandwich ELISA to detect GPCR in NABBs

The primary (capture) antibody was diluted to 1μg/mL in 1xPBS pH 7.2
and 100μL was added to each well of the microplate (Costar clear-bottom, black
96-well). The plate was kept overnight at 4°C. The wells were washed twice with
PBS containing 0.05% Tween-20. The wells were washed once with PBS and
200μL of 10mg/mL (1%) fatty-acid free BSA in PBS. The plate was either
incubated at room temperature for 2 h or overnight at 4°C. The GPCR-NABBs
were added to the respective wells in a final volume of 100μL. The GPCR-NABB
was diluted in PBS containing 1mg/mL (0.1%) BSA. The microplate was
incubated at 4°C overnight to ensure complete binding of epitope on the GPCRNABB to the capture antibody. The analyte was then washed out thrice with 0.1%
BSA-PBS using 200μL per wash. HRP-conjugated secondary (detection)
antibody was added at 0.5-1.0μg/mL in each well (depending on the antibody
affinity to the second epitope on the GPCR-NABB). The plate was incubated at
room temperature for 2 h. The wells were washed 3-4 times with 0.1% BSA-PBS.
A fresh working solution of Amplex Red and H2O2 was prepared from DMSO
stock of Amplex Red and 3% H2O2 according to the manufacturer recommended
protocol (Invitrogen, CA). 50μL of the Amplex Red working solution was
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dispensed in each well and the plate was incubated for 30 min at room
temperature, protected from light. The fluorescence in the wells were measured
using a Cytofluor-II spectrofluorimeter with excitation at 530nm and emission at
590nm.

2.26 High-throughput G-protein activation assay

A black, C-bottom 96-well plate was used for the high-throughput Gprotein activation assay. 25μL of purified G protein or its subunits were added to
the microplate wells from 150 mM protein stock. The proteins added were either
Gi1 subunit, Gi1 with transducin  subunits, or holotransducin (Gt), with 25μL
of buffer G1 without GDP. CCR5-NABBs was incubated with 50 nM RANTES
on ice for 30 min. 100μL of CCR5-NABB solution with and without RANTES
were added to the respective wells and the microplate incubated at room
temperature for 15 min. 60μL of BODIPY-FL-GTPS was added from a 1 μM
stock to all wells using a multi-channel pipettor. The plate was shaken for 30 sec,
covered and incubated at room temperature for 5 min. The fluorescence in the
wells was recorded using a Cytofluor II microplate reader with excitation
wavelength= 485nm and 20nm bandpass, emission wavelength= 530nm and
25nm bandpass. The gain was set to 95 and 15 reads were integrated for each
well. The fluorescence values from the wells containing BODIPY-FL-GTPS and
no G protein was subtracted from the rest of the data as background. The
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fluorescence values from wells containing the CCR5-NABBs with no RANTES
was subtracted from RANTES containing wells to give the RANTES specific
response.
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3.0
Formation and Characterization of
Nanoscale Apolipoprotein Bound Bilayer (NABB)
Particles by Zebrafish Apo A-I (Zap1)

3.1

Introduction

Apolipoproteins have been classified as ‘protein detergents’ (Segrest,
Garber et al. 1994) that stabilize the size and structure of lipoprotein particles.
The main function of apolipoproteins is considered to be lipid transport in the
intravascular and extravascular regions in all organisms where these
apolipoproteins are present (Li, Tanimura et al. 1988). Apo A-I is the main
protein in high density lipoprotein (HDL) particles (density 1.06-1.21 g/mL) and
involved in reverse cholesterol transport in the body. The structure and
mechanism of action of human apo A-I has been a topic of intense investigation
since human apo A-I has been implicated to play a protective role against

Material in this chapter has been previously published in: Banerjee S, Huber T, Sakmar TP. (2008)
Rapid Incorporation of Functional Rhodopsin into Nanoscale Apolipoprotein Bound Bilayer
(NABB) Particles. J. Mol. Biol. 377(4): 1067-81.
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coronary heart disease in humans (Bhat, Sorci-Thomas et al. 2005). Human apo
A-I is a 243 amino acid protein that contains a putative globular N-terminal
domain (residues 1-43) and a lipid-binding C-terminal domain (residues 44-243)
(Segrest, Jones et al. 1992). Analysis of the human apo A-I gene and protein
sequence first gave the idea that apo A-I contains eight 22-mer and two 11-mer
tandem amino acid sequence repeats punctuated by prolines, and encoded by exon
4 of the apo A-I gene (McLachlan 1977; Karathanasis, Zannis et al. 1983).
The 4Å solution X-ray crystal structure of human apo A-I (44-243 amino
acids) (Borhani, Rogers et al. 1997) showed an almost continuous -helix
punctuated by small or large proline induced kinks (Fig. 1-6 A). Apo A-I appears
as four monomers in a unit cell, forming two antiparallel dimers. The dimers form
central helix 5-5 and C-terminal helix 10-10 overlaps. A detailed molecular
‘double-belt’ model of apo A-I was subsequently proposed by considering lipid
bilayer constraints on the arrangement of the protein (Segrest, Jones et al. 1999).
The double-belt orientation of apo A-I (Fig. 1-7) has since been generally
accepted and has proved consistent with recent analyses of HDL structure (Li,
Lyles et al. 2000; Li, Chen et al. 2004; Silva, Hilliard et al. 2005; Li, Kijac et al.
2006).
The common lipid-associating structural motif in all exchangeable
apolipoproteins is the amphipathic -helix and any differences in lipid-binding
properties of the apolipoproteins of similar number of amino acids can therefore
be extrapolated to differences in the properties of the amino acids constituting the
-helices

as

well

as

the

relative
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arrangement

of

the

-helices.

Formation and structural stability of HDL particles is critically dependent on the
following parameters (Catte, Patterson et al. 2006):
1.

Amphiphatic properties of apo A-I helices.

2.

Flat planar discoidal (bilayer) geometry of HDL particles.

3.

Helical curvature of the apolipoprotein dictated by the low dielectric
constant of the lipid tails and high dielectric constant of the solvent.

4.

Critical role of salt-bridges between the apolipoprotein helices to form
a ‘dimer’ of apolipoprotein around the circumference of the bilayer
disc.

The salt-bridging pattern between pairs of identical apo A-I helices from
different species has been estimated by computationally docking one molecule of
apo A-I over the second one in a certain interfacial orientation (Segrest, Jones et
al. 1999). Strikingly, the general pattern of inter-helical salt-bridging in apo A-I is
conserved in birds, mammals and fish. The salt-bridging pattern for zebrafish apo
A-I shows a regular appearance of minima throughout the length of the helix,
compared with human apo A-I where the minima are less regular and often
compensated by charge appositions (Fig. 1-7 E). We hypothesized that this
difference in salt-bridging pattern between zebrafish and human apo A-I may
indicate that zebrafish apo A-I may adopt a higher number of stable inter-helical
orientations compared with human apo A-I – a property that may enable us to
utilize zebrafish apo A-I for forming discoidal lipoprotein particles rapidly and
with stability even upon dilution. Although there have been scarce reports on the
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properties of fish apo A-I, it has mainly been implicated in a direct functional role
of maintaining trans-epithelial resistance in rainbow trout gills (Smith, Wood et
al. 2005).
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Figure 3-1. Sequence Comparison of Zebrafish apo A-I with Human
apo A-I

Amino

acid

sequence

comparison

of

mature

zebrafish

apolipoprotein A-I with human apolipoprotein A-I. (Top) Amino acid
sequence alignment of D. rerio (Z) apo A-I, aligned with H. sapiens (H)
apo

A-I

was

performed

using

ClustalW

1.8

program

(http://www.ebi.ac.uk/clustalw/). Invariant amino acid residues are shown
in red and chemically similar residues are shown in green. Residue on
zebrafish apo A-I that was chosen for a single point mutation to Cys in
zap1Q26C is marked with *. N-terminal deletion for human 1–43 apo AI is also marked. (Bottom) Domain structure of hexa-histidine tagged
zebrafish apo A-I construct (zap1) and human 1–43 apo A-I (hap1)
cloned and purified as described (Materials and Methods).
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Figure 3-1. Sequence Comparison of Zebrafish apo A-I with Human
apo A-I
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3.2

Results

3.2.1 Amino Acid Sequence Comparison between Human Apo A-I and
Zebrafish Apo A-I

In a discoidal High Density Lipoprotein (HDL) particle, two molecules of
human apo A-I are hypothesized to form a ‘double-belt’ around the discoidal lipid
particle that run circumferentially anti-parallel to each other (Segrest, Jones et al.
1999). The amphipathic helices are punctuated by periodic proline residues,
which are believed to kink the helices to facilitate forming of the circumferential
belt with the helix axis perpendicular to the lipid acyl chains. An apolipoprotein
that binds to lipids in a manner similar to human apo A-I to form discoidal lipid
particles would share a similar distribution of amino acids. To test the
conservation of amino acid patterns between the two apolipoproteins, an amino
acid sequence alignment was performed (Fig. 3-1). Invariant proline residues
occur every 22 or 11 amino acids, suggesting that the length of zebrafish apo A-I
may be divided into tandem 22/11-mer helices which interact with the lipid side
chains and are punctuated by proline ‘hinges’, similar to the hypothesized lipidbinding mechanism of human apo A-I. The alignment also shows a general
conservation of the chemical type of the amino acid residue in zebrafish apo A-I
at the corresponding positions of the human apo A-I. The sequence similarity
points to a similar lipid binding mechanism and amphipathicity of zebrafish apo
A-I compared with human apo A-I. Hydropathy analysis shows the C-terminal
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residues may not be as important for lipid binding in zebrafish apo A-I compared
with human apo A-I. N-terminal tails of both zebrafish and human apo A-I show a
conserved pattern of high hydrophobicity, indicating a possible role of the Nterminal residues of zebrafish apo A-I in lipid binding.
Human apo A-I is known to form various HDL subclasses distinguished
on the basis of the diameters of the discoidal complexes (Jonas, Kezdy et al.
1989; Jonas, Steinmetz et al. 1993). The amino acid sequence of apo A-I is
considered to be the primary determinant of HDL subclass formation. Most
species, for example mice, generate monodisperse HDL particles, whereas
primates and humans make distinct HDL subclasses. The two major subclasses
being HDL2 (larger and more buoyant) and HDL3 (smaller) (Reschly, SorciThomas et al. 2002). A major difference between the amino acid sequences of apo
A-I in humans and non-primates is the lack of a Pro residue between putative
helices 7 and 8 in human apo A-I (Frank and Marcel 2000). A report comparing
the effects of replacing the non-proline containing sequence between helices 7
and 8 in human apo A-I with a proline containing sequence led to preferential
formation of HDL2 (smaller discs) by the chimeric human apo A-I (Carnemolla,
Ren et al. 2008). Notably, zebrafish apo A-I contains a proline at position 186
(Fig. 3-1) which is the region between putative helices 7 and 8, with no
corresponding proline at the same position in human apo A-I. The presence of
Pro186 in zebrafish apo A-I may be a possible reason for the monodisperse nature
of discoidal liproprotein particles formed by zebrafish apo A-I NABBs, compared
with human apo A-I.
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3.2.2 Salt Bridging between Apo A-I Helices

We analyzed the distribution of amino acids on zebrafish apo A-I using
the HELNET program (Fig. 3-2 A, B). This program creates a diagram of the 
helix seen as a cylinder cut along the center of the polar face and flattened. A
continuous  helical net display of the putative tandem helices formed by the Cterminal 200 amino acids was plotted using either a pitch of 3.6 residues (18/5)
per turn (Fig. 3-2 A) , or a ‘tighter’ pitch of 3.6667 residues (11/3) per turn (Fig.
3-2 B). As seen in the amino-acid distribution in the 18/5 helix, if the helix were
closed as a cylinder, the hydrophobic face would twist around the resulting torus,
instead of lying at the center of the helix as required by the double-belt model
(Segrest, Jones et al. 1999). If the amino-acids are arranged according to a 11/3
helix, a comparatively straight (planar) hydrophobic face is formed. Further, we
saw a marked separation of positively charged residues and negatively charged
residues on respective edges of the helical net in the 11/3 helix (Fig. 3-2 B). Such
a separation may be critical to the formation of effective and long-range saltbridges between two anti-parallel arrangements of the zap1 helices in a discoidal
lipoprotein particle. However, the HELNET program does not account for the
special role of proline residues in the sequence, the presence of which may break
the pattern of amino-acids.
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Figure 3-2. Helical Net Analysis and Salt Bridging Scores between
Zebrafish Apo A-I Helices

(A) Arrangement of hydrophobic (black), positively charged (blue)
and negatively charged (red) amino acids in zebrafish apo A-I (Zap1)
when Zap1 adopts a regular  18/5 helix. Zap1 was plotted with an
idealized pitch of 3.6 residues/turn using the HELNET program. (B)
HELNET plot of zap1 with the amino acid residues arranged in an
11/3 helix with 3.6667 resuidues per turn of the helix. A difference in
the distribution of hydrophobic and charged amino acids can be seen in
these two types of helical arrangements. Clustering of charged amino
acids towards the edges of the helix and hydrophobic amino acids towards
the center is observed in the 11/3 helix configuration (C) Weighted salt
bridging scores of two zap1 molecules arranged in an –11/3 helix. Salt
bridging scores using all possible ring pair interfaces between the 2 zap1
molecules are shown. Antiparallel arrangements- left to left (LL) and right
to right (RR). Parallel arrangements- left to right (LR) and right to left
(RL). For each residue step (x axis) representing one docking position,
each weighted score is shown (y axis). The weighted number of salt
bridges and like charge appositions were calculated for each docking
position using the ALIGN program. The net salt bridging score is
favorable only in the LL (antiparallel) arrangement of the helices.
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Figure 3-2. Helical Net Analysis and Salt Bridging Scores between

Zebrafish Apo A-I Helices
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Salt bridging between the apo A-I helices is reported to play a crucial role
in determining the specificity of the helix-helix registry in a HDL particle
(Segrest, Jones et al. 1999; Klon, Jones et al. 2000; Klon, Segrest et al. 2002).
Molecular dynamics simulations of model peptides with POPC bilayer has shown
that interhelical energetics is dominated by salt bridges (Sheldahl and Harvey
1999). We used the ALIGN program (Segrest, Jones et al. 1999) to compare the
weighted salt-bridging score between helices in mature zebrafish apo A-I and
human apo A-I proteins (Fig. 3-2). A lower score indicates more favorable salt
bridging (attractive forces) between helices at that position. We noticed that both
apolipoproteins have a net favorable salt bridging score when the two apo A-I
helices are in antiparallel orientation with respect to each other (Fig. 3-2). We
also noticed that zebrafish apo A-I exhibited a more regular pattern of negative
peaks (favorable salt bridges) in the score throughout the length of its helix
compared with human apo A-I. This may point to a mechanism in zebrafish apo
A-I where multiple possible helical registries are possible, as opposed to one
particular more favorable registry as with human apo A-I. It is likely that by not
constraining the relative orientations (helix registers) of the apo A-I helices,
zebrafish apo A-I may be able to form discoidal lipid particles rapidly. The
particles formed by zebrafish apo A-I may also be more resistant to dilution
compared with human apo A-I since the zebrafish apo A-I helices will be able to
dock in multiple orientations in an equilibrium between lipid-bound and lipid-free
states at high dilutions.
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Figure 3-3. Vector Map and Purification of Zebrafish Apo A-I

(A) Vector map showing the salient features of the pE28-ZAP1
DNA derived from the pET28a(+) vector. Restriction endonuclease sites
utilized for preparing and checking the vector are shown. (B) Ni-affinity
purification of zap1 was performed and His-tagged protein eluted with an
imidazole gradient. (C) Gel-filtration chromatography using a Superdex
200 26/60 column showed that the zap1 formed tetramers in the gelfiltration buffer. The tetramer peak was pooled to obtain pure zap1 (>95%)
as shown in the inset. The presence of truncated protein (trunc.)
contaminates the monomer peak, but not the tetramer. The inset shows
Coomassie Blue stained fractions of lysate and the tetramer peak from the
Superdex 200 column. The rightmost lane shows fluorescent detection of
Alexa-488 modified zap1Q26C protein cloned and labeled as outlined in
Method 2.11 and 2.12, and purified under similar conditions.
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Figure 3-3. Vector Map and Purification of Zebrafish Apo A-I
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3.2.3 Purification and Site-specific Fluorescent Labeling of Zebrafish
apolipoprotein A-I (zap1)

We used reverse-transcriptase PCR to generate zebrafish apo A-I cDNA,
which was inserted in a high-fidelity protein expression vector pET28a(+)
(Novagen, San Diego, CA). The resulting vector- pE28ZAP1 (Fig. 3-3 A) had the
zap1 sequence transcribed by the T7 RNA polymerase, under control of the lacI
promoter which was de-repressed by

the addition of isopropyl--D-

thiogalactoside (IPTG) (Glick and Pasternak 1994). The vector carried a
Kanamycin resistance marker which was used for selecting colonies containing
the vector on a LB-Agar plate (or other media) supplemented with 50μg/mL
Kanamycin. The vector also carried a hexa-histidine coding region upstream of
the zap1 sequence, followed by a PreScission protease cleavage site. We also
prepared a bacterial expression vector coding for human apo A-I using pET16b
vector (Novagen). Human apo A-I cDNA was obtained from ATCC, excised and
inserted into pET16b vector using appropriate restriction endonucleases. The
resulting vector- pE16HAP1 contained the human apo A-I sequence transcribed
by T7 RNA polymerase, under control of the lacI promoter. The vector carried an
Ampicillin resistance marker, and a hexa-histidine coding sequence upstream of
the hap1 sequence, followed by a Factor Xa protease cleavage site. Subsequent
site-directed mutagenesis reactions were performed on these DNA constructs.
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After E. coli expression and cell lysis, the hexa-histidine tag was used to
affinity purify zap1 on a Ni column, using an imidazole gradient (Fig. 3-3 B).
Gel-filtration chromatography of Ni-affinity purified hexa-histidine tagged
zebrafish apo A-I (zap1) yielded protein at greater than 95% purity as judged by
densitometry of the SDS-PAGE lane (Fig. 3-3 C). The tendency of apo A-I to
form higher order oligomers was exploited in the gel-filtration step; the highest
purity of zap1 on SDS-PAGE was the fraction corresponding to the size of a zap1
tetramer. A large amount of protein in the subsequent fractions was truncated as
judged by SDS-PAGE. The truncation may either be due to aborted protein
synthesis of zap1 in E.coli or proteolysis of the full-length protein in the bacteria.
The ability of the truncated products to be co-purified on the Ni-affinity column
alongwith the full-length zap1 under denaturating conditions indicates that the
truncation occurred from the C-terminus (the hexa-histidine tag is present on the
N-terminus).
A putative solvent-accessible glutamine residue near the N-terminus was
chosen for point mutation to cysteine (shown by * in Fig. 3-1) to enable coupling
to maleimide-linked fluorophores. For labeling the Cys mutant, a protocol
reported for an on-column labeling procedure (Bergendahl, Anthony et al. 2002)
was followed with slight modifications.
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Figure 3-4. Native Polyacrylamide Gradient Gel Electrophoresis of
NABBs

NABBs were prepared using LRB-DOPE doped POPC and zap1 in 75
POPC : 1 zap1 ratio. (Top panel) Gray curve— Densitometric scan of the
fluorescence distribution in the gel lane after detection of rhodamine
fluorescence

(corresponding

to

doped

lipids).

Black

curve—

Densitometric scan of protein distribution made after Coomassie Blue
staining of the same lane. The Stokes’ diameter was calculated from the
migration of standard proteins with known hydrodynamic radii in adjacent
lanes: Thyroglobulin 17nm, Ferritin 12.2nm, Catalase 9.2nm, Bovine
Serum Albumin 7.1nm. (Bottom panel) Lane showing protein distribution
detected by Coomassie blue staining and lipid distribution detected by
rhodamine fluorescence of the same lane. The gel was run to equilibrium
in Tris-Borate-EDTA pH 8.5 for 24 h at 16°C.
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Figure 3-4. Native Polyacrylamide Gradient Gel Electrophoresis of
NABBs
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3.2.4 Characterization of Lipoprotein Particles formed by Zebrafish Apo
A-I

The products of the interaction of zebrafish apo A-I (zap1) and POPC
upon detergent removal were characterized by native polyacrylamide gradient gel
electrophoresis, and gel-filtration chromatography followed by electron
microscopy imaging. The native gradient gels were analyzed at equilibrium by
running the gels for 24 h at 16°C (Fig. 3-4). Under these conditions, the particles
migrate due to a combined influence of the net charge on the particle (primarily
due to zap1, since POPC is a zwitterionic lipid) and sieving effects of the crosslinked agarose gel.
To observe the effect of different POPC ratios on the hydrodynamic radius
of NABBs, different POPC to zap1 ratios were used to reconstitute NABBs by
extensive dialysis to remove detergent. The NABB samples were then analyzed
by gel-filtration chromatography on a calibrated Superose 6 10/30 column. Three
POPC to zap1 ratios are shown in Fig. 3-5. We detected evidence of three particle
populations with maximal Stokes diameters of 10nm, 11.6nm, and 12.5nm in
addition to a void volume fraction containing vesicles. Upon increasing the
POPC:zap1 ratio to 100:1, we also detect a significant population of 17nm
diameter discs.
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Figure 3-5. Gel-filtration, EM imaging and Histogram of Diameters of
Lipoprotein Particles formed by zebrafish apo A-I

(A) Formation of discoidal lipoprotein particles by zebrafish apo
A-I with POPC. Size-exclusion chromatography of lipoprotein particles
formed between zebrafish apo A-I and POPC upon detergent removal by
dialysis at different molar ratios of POPC to zap1— 25:1, 75:1, and 200:1.
The Stokes’ Radii determined by calibration of the Superose 6 10/30
column

were:

a-12.5nm,

b-11.6nm,

c-10.0nm,

v-void

volume.

Representative negative stain EM images of the main peak fractions
(shaded area) are shown as insets. The scale bar in all cases is 50nm. (B)
A histogram of the size distribution of particles formed by zebrafish apo
A-I and POPC at a POPC to zap1 ratio of 75:1 from EM imaging.
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Figure 3-5. Gel-filtration, EM imaging and Histogram of Diameters of
Lipoprotein Particles formed by zebrafish apo A-I
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In comparison, Rogers et al. (Rogers, Brouillette et al. 1997) have
reported that human apo A-I forms particles of diameters 8.5nm (78%), 12.0nm
(21%) and 15.5nm (1%) with POPC, whereas human 1-43 apo A-I gives
particles of diameters 8.5nm (47%), 12.5nm (18%) and 16.5nm (35%). These
results are consistent with our experience. Compared with zap1 and POPC which
tends to form a homogeneous disc population, hap1 forms discs with a broad
and heterogeneous size distribution. A smaller diameter of NABBs in very low
POPC: zap1 ratios could either be explained by correspondingly smaller number
of amino acids contacting the lipid which is limiting, resulting in a ‘buckling’ of
the planar disc structure (Catte, Patterson et al. 2006). When the lipid: zap1 ratio
is in large excess of the optimized ratio for disc formation, the dominant product
is vesicles. We confirmed discoidal morphology of the NABBs by negative stain
EM and observed typical rouleaux (stack) formations of NABBs as well as welldefined separated NABBs with average diameters of 10–13nm and thickness of
about 5nm as the main structures when the molar ratio was 75 POPC:zap1.

Sizing of the particles was done from the images using the magnification
parameters of the image in the ImageJ software image analysis program.
Measurements of diameter were done on free-standing particles with a circular
profile and plotted as a histogram (Fig. 3-5 B).
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Figure 3-6. Circular Dichroism (CD) and Isothermal Titration
Calorimetry (ITC) of zap1 Interaction with POPC Small Unilamellar
Vesicles (SUVs)

(A) Far UV CD spectra are shown for 6His zebrafish apo A-I (zap1) in
buffer (empty circles) or in buffer containing POPC SUVs (filled circles).
Spectra are also shown for 6His human 1–43 apo A-I (hap1) in buffer
(empty triangles) or in buffer with POPC small unilamellar vesicles (filled
triangles). (B) ITC time trace of zap1 injected into dispersion of POPC
SUVs. The heat of injection (lower panel) is plotted by integrating the area
under each injection peak (upper panel). The last few injections were
taken as the heat of dilution and subtracted from the entire run.
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Figure 3-6. Circular Dichroism (CD) and Isothermal Titration
Calorimetry (ITC) of zap1 Interaction with POPC Small Unilamellar
Vesicles

(SUVs)
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Table 1. Interaction of Apo A-I with POPC Vesicles
CD parameters for zap1 and hap1*
Sample

[]222 103

fh

Residues

zap1 in buffer

14.4±0.3

0.38

102

zap1 + POPC

20.7±0.3

0.55

147

hap1 in buffer

12.9±0.4

0.33

76

hap1 + POPC

17.0±0.1

0.45

101

ITC parameters of POPC interaction with zap1 and hap1
Sample

Ka (M 1)
10 6

zap1

4.09±0.80

N (mmol
apo/mol
POPC)
1.91±0.05

0.55±0.95

1.70±0.14

G° a
(kcal/mol)

TS° b
(kcal/mol)

59.7±1.1

11.6

48.0

98.5±1.1

10.4

88.1

H°
(kcal/mol)

+ POPC
hap1
+ POPC

* Experiments were performed at 25°C.
** Experiments were performed at 30°C. Each value represents the average of at
least three experiments. The H° and S° values are per mole of apo A-I.
a

G° = RT ln(55.5M  K a ) (Rogers, Brouillette et al. 1997; Seelig 2004)

b

TS° = H°  G°
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3.2.5 Interaction of Zebrafish Apo A-I with Lipid Vesicles

We compared the lipid-mediated helicity change and thermodynamics of
zap1 with that of an N-terminal 1–43 amino acid truncated human apolipoprotein
A-I (hap1) construct that has been hypothesized to form a model antiparallel
double-belt orientation around a HDL particle (Borhani, Rogers et al. 1997) and
has been used to incorporate membrane proteins (Bayburt, Grinkova et al. 2002).
It is noteworthy that apo A-I interaction with POPC SUVs does not form NABBs.
However, the interaction of lipid-free apo A-I with the phospholipid membrane of
the SUV induces -helical structure (White and Wimley 1999; Seelig 2004),
which may be measured using circular dichroism (CD) spectroscopy and
isothermal titration caloriemetry (ITC). The conditions in our CD experiments are
similar to those in Arnulphi et al. (Arnulphi, Jin et al. 2004), who reported
interaction of mature human apo A-I with POPC SUVs. The data for Molar
Residue Ellipticity (MRE) obtained by them for human apo A-I are similar to our
data using zap1. Surprisingly, the fractional helicity (fh) obtained by us for zap1
(Table 1) using the empirical relation of Scholtz et al. (Scholtz, Hong et al. 1991)
are 20-25% lower than what Arnulphi et al. report for human apo A-I. However,
based on the similarity of the two proteins and experimental conditions, the fh
values of human apo A-I and zap1 should be identical since the MRE values are
virtually identical. Rogers et al. (Rogers, Brouillette et al. 1997) and Li et al. (Li,
Chen et al. 2004) have reported comparisons of human apo A-I with N-terminal
1-43 truncated human apo A-I (similar to hap1). The MRE values reported in
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these papers are systematically higher than those of either Arnulphi et al. or ours.
Interestingly, these two papers seemingly contradict each other in the extent of
helicity of human apo A-I and hap1. The discrepancy between our data and the
published data highlighted above are likely due to an instrumental artifact of the
CD spectrometer used in these studies that appears to give systematically lower
ellipticity values, not unusual for CD instruments (Konno, Meguro et al. 1975).
Despite the difficulties in comparing data from different groups, our data in Table
1 clearly indicate that zap1 undergoes a larger increase in helicity compared with
hap1 upon interacting with POPC SUVs. Apparently, nearly twice as many
amino acid residues become -helical in zap1 compared with hap1 upon
interaction with POPC SUVs.
Comparing the affinity of apo A-I to POPC SUVs from our data (Table 1)
and from Arnulphi et al. (Arnulphi, Jin et al. 2004), we found that the association
constant (Ka) for zap1 is more than 7-fold greater than that of hap1, but
approximately equal to that of human apo A-I. On the other hand, the
stoichiometry of binding of zap1 and hap1 to POPC are similar but 3-times
higher than reported for human apo A-I. The reaction enthalphy (°) shows that
zap1 has only about 60% of the favorable reaction enthalpy compared with hap1
and human apo A-I. It is interesting to note that while zap1 shows significantly
reduced values of enthalpic and entropic contributions to the free energy change
compared with hap1, enthalpy-entropy compensation results in similar G°
values for both apolipoproteins. In both cases the interaction with POPC is
enthalpy driven.
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3.3

Discussion

3.3.1 Biological Role of Apo A-I

The main role of apolipoprotein A-I in most organisms where it is found is
in the reverse cholesterol transport (RCT) pathway. In RCT, lipids and free and
esterfied cholesterol are carried from peripheral tissues to the liver by High
Density Lipoprotein (HDL) particles. These HDL particles are formed by lipids
and apo A-I, with 1–4 apo A-I molecules per HDL (Fielding P.E. and C.J. 2002),
together with other apolipoproteins that specify the metabolism and delivery of
these lipids. Newly formed HDL have high density primarily due to apo A-I and
little lipid. Their density decreases as they take up lipid in the circulation. The
classical subfractions of HDL are– HDL3 (density 1.12-1.219 g/mL), HDL2
(1.063-1.12 g/mL), HDL1 (density < 1.063 g/mL).
In humans, apo A-I is synthesized by the liver and small intestine. HDLcontaining apo A-I is formed in the extracellular space. Lipid-poor apo A-I
associates with cell-derived phospholipids and cholesterol. The association of apo
A-I and phospholipids is thermodynamically favorable; phospholipid-free mature
human apo A-I has not been detected in biological fluids.
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3.3.2 Evolution of Apo A-I

Apolipoproteins are lipid binding proteins comprising of amphipathic
helices. Apo A-I is conserved throughout evolution from insects (called
apolipophorins) to humans with its primary function being lipid binding and
transport. The majority of the structural and functional aspects of apo A-I had
been elucidated due to extensive studies on human apo A-I. Apo A-I is
synthesized in-vivo in the liver and small intestine as a 267 amino acid preproapoA-I. The proapoA-I is secreted into the plasma after an intracellular
peptidase cleaves the 18 amino acid signal sequence from pre-proapoA-I
(McGuire, Davidson et al. 1996). The propeptide sequence of 6 amino acids is
removed by an unknown protease, releasing the mature apo A-I protein.
Inspection of the amino acid sequence of pre-proapo A-I and apo A-I reveals that
a large part of the protein evolved by duplication of a primordial sequence
encoding a 22 amino acid sequence (22-mer). This primordial sequence seems to
have evolved by a duplication of an 11-mer sequence (Boguski, Elshourbagy et
al. 1985).
Synthetic amphipathic helical segments whose primary sequence is
unrelated to that of native apo A-I can be effective mimics of natural apo A-I in
binding to phospholipids, promoting cholesterol efflux from cells, and activating
the formation of cholesteryl esters by the LCAT reaction (Nion, Demoor et al.
1998; Wool, Reardon et al. 2008). Some repeats in native human apo A-I have
been reported to be of more significance than others for the function of HDL
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particles (Sorci-Thomas, Curtiss et al. 1997). The reports indicate that apo A-I
may retain significant tertiary structure

3.3.3 Hi-yield Expression and Purification Strategy for Apo A-I

Hi-yield heterologous expression of apo A-I was optimized by adapting
strategies previously reported for human apo A-I expression and purification
towards zebrafish apo A-I (McGuire, Davidson et al. 1996; Rogers, Roberts et al.
1998; Bayburt, Grinkova et al. 2002). A hexa-histidine tag was introduced
upstream of the N-terminus of zap1 in the bacterial expression plasmid. The zap1
cDNA contained some rare codons for E.coli due to which an engineererd E. coli
strain was chosen which contains an additional plasmid coding for rare E. coli
amino acids (BL21DE3 Rosetta2) instead of codon optimizing the DNA. The
bacterial strain chosen was also deficient in proteases, since apo A-I being a
flexible protein, could be susceptible to proteolysis in the bacterial cell. Evidence
of truncated proteins was observed however, and may be attributed to aborted
protein translation in E.coli. Enriched bacterial culture media, called Terrific
Broth, was used to maximize bacterial growth. The bacterial cells were lysed in
the presence of a chaotrope (6M guanidine hydrochloride) or detergent (1%
Triton X-100) in order to solubilize the hydrophobic stretches of apo A-I by
delipidation for further purification.
In a solution of 6M guanidine hydrochloride or 1% Triton X-100, the apo
A-I is mostly unfolded. The apo A-I is refolded on the Ni column by washing the
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column with decreasing concentration of guanidine hydrochloride or Triton X100. On-column labeling of zap1Q26C may be performed in a partially unfolded
state of the protein by flowing the maleimide-functionalized fluorophore at
approximately 1mM concentration in the wash buffer without any reducing agent.
If Triton X-100 is used for solubilization, then a washing step with 2mM sodium
cholate is recommended to separate any charged impurities. The final washes of
the Ni column are chaotrope or detergent free. The protein is eluted using an
imidazole gradient. Gel-filtration chromatography is carried out to obtain
fractions with ful-length zap1 at different purities (Fig. 1-3 C). We have observed
both zebrafish and human apo A-I to have a strong tendency to form non-covalent
dimers and tetramers when free of chaotropes or detergents. Full-length apo A-I
of very high purity (>92%) may be isolated from the gel-filtration peaks
corresponding to a tetramer. The monomer peak usually overlaps with a peak
containing truncated protein in a Superdex 200 column and is thus not usable.
The pure apo A-I may be stored for extended periods of time at 4°C or in
standard buffers without any loss in lipid-binding activity. The apo A-I does tend
to aggregate over time, therefore it is advisable to store small aliquots at -20°C.
When thawing an aliquot for use, it is advisable to centrifuge the tube and make a
fresh dilution of apo A-I from the supernatant and determine the concentration (by
UV absorbance) before starting an experiment.
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3.3.4 Molecular Basis of in-vitro Discoidal Lipoprotein Formation by Apo
A-I

Salt bridges are weak, ionic forces between positively and negatively
charged side chains of amino acids. The contribution of a single salt bridge may
be as much as –5 kcal/mol (Schulz G.E. and R.H. 1979) and is heavily dependent
on the electrostatic properties of the medium. The contributions of salt bridging
are more important for determining specifity between protein-protein interactions,
rather than the overall stability of the protein. If the charges of oppositely charged
proteins, or protein surfaces are not compensated, the energy is reduced
sufficiently such that the proteins will not associate.
Most of the experimental evidence on apo A-I and HDL structure has been
obtained from synthetic recombinants of human apo A-I and pure phospholipids
in a range of relative molar ratios. The particles have been shown to consist of a
planar phospholipids bilayer, whose edges are sealed from the aqueous medium
by apo A-I. It was thought earlier that a ‘picket fence’ model- where the helical
repeats of apo A-I were at right angles to the lipid bilayer, accurately reflected the
structure of these particles (Brasseur, De Meutter et al. 1990; Phillips, Wriggers et
al. 1997). The more recent ‘double belt’ model predicts the helical repeats to be
aligned circumferentially parallel to the bilayer (Segrest, Jones et al. 1999;
Tricerri, Agree et al. 2001). The double-belt model of apo A-I binding to lipids is
the currently accepted model.
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Figure 3-7. Intermediates in a Micelle-to-Vesicle Transition

Schematic

representation

of

a

proposed

micelle-to-vesicle

transition pathway adapted from Leng et al. (Leng, Egelhaaf et al. 2003).
Detergent removal from mixed micelles is believed to first form disc-like
intermediate micelles rapidly. These micelles grow up to a certain critical
radius (r*) due to coalescence, followed by closure to form vesicles.
Ripening of these vesicles is thought to occur over very long timescales.
Under certain conditions, there may be a significant barrier to coalescence
(depending on electrostatic interactions between disks and packing
contributions), and growth and closure may be slower than stacking. This
leads to the formation of lamellar phase as the end state.
In a NABB, apo A-I may replace the detergent at the edge of the
disc, thereby increasing the stability of the kinetically trapped discoidal
intermediate (section 3.3.4).
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Figure 3-7. Intermediates in a Micelle-to-Vesicle Transition
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Discoidal lipid particles are hypothesized to be intermediates in a micelleto-vesicle transition reaction of lipids upon detergent removal, as deduced from
static and dynamic light scattering experiments (Leng, Egelhaaf et al. 2003). In
the absence of apo A-I, when a detergent is removed from a mixed-micellar state
of lipids and detergents, disc-like intermediate micelles are first formed rapidly
(Fig. 3-7). These disc-like micelles grow by coalescence. Interactions between
disc-like micelles are determined by the standard electrostatic potential of the
system in addition to local packing contributions between the discs. Large discs
then become unstable due to incomplete coverage of their perimeter by detergent
which increases the energy per unit length of boundary (line tension) of the disc,
finally leading to closure of the large lipid disc to form a lipid vesicle. Line
tension may control the initial diameter of the disc-like micelles.
It is plausible that apo A-I present at a certain concentration replaces the
surfactant stabilizing the edge of the bilayer due lipid-binding properties of its
amino acids, as shown in red in Fig. 3-7. This would provide kinetic stability to
the disc-like micelle formed. It should be mentioned that this proposed scheme of
NABB formation is valid only when NABBs are formed by detergent removal
from a mixed micellar state. Human apo A-I is able to directly solubilize vesicles
around their phase transition temperature (Tm) of the vesicle lipids (Tricerri,
Toledo et al. 2005). The vesicles formed with dimyristoyl phosphocholine
(DMPC, Tm= 28°C) or dipalmitoyl phosphocholine (DPPC, Tm= 40°C) are
among those that are solubilized by apo A-I. The NABB formation pathway in
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these cases likely involves interaction of apo A-I with lipids facilitated by
interfacial packing defects in the lipids during the gel to liquid-crystalline phase
change. Using lipids such as 1-palmitoyl-2-oleoyl phosphocholine (POPC,
Tm= –3°C) or 1-palmitoyl-2-oleoyl phosphoethanolamine (POPE, Tm= 17°C)
(Leekumjorn and Sum 2007), which are already in liquid crystalline phase under
experimental conditions, detergent removal is the preferred method for formation
of NABBs.

3.3.5 Electron Microscopy of Discoidal Lipoprotein Particles

Electron microscopy (EM) is an extremely useful tool for obtaining insight
into particle size distributions and morphology under conditions where sample
size is extremely small and/or dilute. Biological materials examined by EM
generally have poor inherent electron scattering characteristics. A commonly used
solution is using negative-staining where heavy metal salts are used that can be
air-dried to give an amorphous electron-dense layer surrounding and supporting
(embedding) the biological particles (Harris 1997). Negative-stain EM lends itself
extremely well in examination of smaller, dense lipoproteins such as low-density
lipoproteins (LDL) and high-density lipoproteins (HDL) (Forte, Nichols et al.
1971; Wlodawer, Segrest et al. 1979; Bayburt and Sligar 2003; Catte, Patterson et
al. 2006). Negative-stains commonly used in EM are uranyl acetate,
phosphotungstate, and ammonium molybdate. Uranyl acetate is favored for most
applications because of its low-granularity and high contrast. The pH of this stain
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is 3.5 to 4.0 and can only be used for dilute protein samples, otherwise
aggregation and precipitation of the protein may occur.
We performed negative-stain EM on 400-mesh formvar carbon coated
grids. The grids were glow-discharged for 20-30 sec prior to sample application to
render them hydrophilic to not have the lipoprotein particles orient in any
particular order. The lipoprotein particles were freshly prepared and examined in
the electron microscope within 1 hour of preparing the grid. To get good contrast,
a relatively low accelerating voltage of 80 kV was used in the microscope. An
optimal defocus was used for imaging, one that showed minimal granularity of
the background stain. Each grid was adequately sampled by taking random
images within a grid square and then imaging in random grid squares to get a
representative set of particles for analysis.
Aggregation of lipoprotein particles on the grid provide additional
information on the physical properties of the particles. Under negative-staining
techniques, discoidal lipoproteins form ‘stacks’ or rouleaux owing to their planar
shape and discoidal geometry. These structures were predominantly seen at
defined lipid:apo A-I ratios, indicating the optimal stoichiometry of components
required to form small, discoidal particles having the thickness of a phospholipids
bilayer.
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4.0
Site-Specific Labeling of Rhodopsin

4.1

Introduction

Derivatization of GPCRs with fluorescent probes at a specific site and
their characterization is a crucial and challenging step in elucidating the molecular
mechanisms of GPCR activation. Chemical modification of an amino-acid side
chain with a fluorophore of small molecular weight is a desirable strategy for
labeling to detect relative conformational change between protein microdomains
or monitoring oligomerization of proteins. The sulfhydryl group of cysteine side
chains is the first target for such modifications because of the following reasons:
1. The cysteine content of most proteins is relatively low (< 3 mol%)
allowing easy discrimination and identification of individual
sulfhydryl groups.
2. A large variety of very specific reagents are commercially available,
including

compounds

that

introduce

reporter

groups

for

spectrophotometric, fluorometric, ESR, NMR, and biochemical
analysis.
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3. The SH group reactivity is fast without the requirement of a catayst.

Bovine rhodopsin has 10 cysteine residues at positions 110, 140, 167, 185,
187, 222, 264, 316, 322 and 323 (Hargrave, McDowell et al. 1984). Cys 110 and
187 form a disulfide bond, Cys 322 and 323 are palmitoylated and Cys 167, 222
and 264 are buried inside the transmembrane helices (Palczewski, Kumasaka et
al. 2000). Previous studies have indicated that Cys 140 and Cys 316 on the
cytoplasmic side are found to be reactive towards maleimide and iodoacetamide,
and of these residues, Cys 316 appears to be more reactive (Findlay, Barclay et al.
1984; Imamoto, Kataoka et al. 2000). In this chapter we discuss methods used to
label and characterize bovine rhodopsin at these reactive cysteine residues.
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Figure 4-1. Fluorescent Derivatization of Rhodopsin

(A) Stochiometry of rhodopsin labeling by commercially available
maleimide-linked fluorophores. Plot of the molar excess of dye (x axis)
and the final labeling ratio of detergent solubilized, affinity purified
rhodopsin (y axis) determined by UV-visible difference photobleaching
spectroscopy. For most dyes, the extent of labeling increases linearly with
increasing dye concentration above a certain threshold. (B) Detection of
site-specific labeling using V8 protease digestion of labeled rhodopsin.
Coomassie stained gel lanes containing unlabeled rho (lane 1), V8
digested Atto655:rho initial ratios of 9:1 (lane 3) and 3:1 (lane 4) are
shown. Fluorescence detection of the gel was done prior to Coomassie
staining. The fluorescence of the respective Atto655 labeled rho samples
are shown in lane 5 and 6. V8 digestion of rho results in two main
proteolyzed fragments- F1 and F2. Cys 316 is present in the F2 fragment.
Selective modification of Cys 316 may be inferred from the fluorescence
signal appearing exclusively in the F2 fragment in lane 6, compared with
both F2 and F1 in lane 5.
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Figure 4-1. Fluorescent Derivatization of Rhodopsin
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4.2

Results

4.2.1 Rhodopsin Labeling with Fluorophore Maleimides

The relation between molar excess of different dyes at the start of the rho
labeling reaction and the final molar ratio of dye to rho is shown in Fig. 4-1. The
fluorophores used exhibited differences in the optimal molar ratios required to
achieve stoichiometric labeling of rho in ROS. When the dyes were used at
equimolar ratios to rho, all of them resulted in sub-stoichiometric labeling of rho.
Among the dyes tested, Alexa-546 led to the most efficient labeling of rho in
terms of lowest dye excess required to achieve stoichiometric labeling (1:1
Dye:Rho). Atto-655 also exhibited efficient labeling of rho and appeared to be an
ideal

fluorophore in

the long-wavelength

region

to

label

rhodopsin.

Stoichiometric labeling was achieved with a 3-times molar excess of Atto-655
over rho, and two cysteines could be modified by doubling the initial dye excess
(9-fold molar excess over rhodopsin) (Fig. 4-1 A).
Rhodopsin was labeled in ROS in order to enhance the reactivity
difference between the two accessible cysteines– Cys 316 (more reactive) and
Cys 140 (less reactive). We assumed that Cys 316 and Cys 140 would get
sequentially modified by the maleimide dyes due to their reactivity difference. To
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test this assumption, we carried out V8 protease digestion of labeled rhodopsin
and analyzed the fragments for fluorescence using SDS-PAGE (Fig. 4-1 B). V8
protease cleaves rho mainly into 2 fragments with Cys 140 being part of the larger
fragment F1 (~27 kD) and Cys 316 being a part of the smaller fragment F2 (~13
kD) (Farrens, Altenbach et al. 1996). As seen from the gel, the stoichiometric
labeling condition for rho using Atto-655 (3:1 Atto-655:rho) predominantly
modifies Cys 316.

4.2.2 Rhodopsin Labeling with Nanogold Maleimide

Nanogold® (Nanoprobes, NY) is a homogenous 1.4nm gold cluster that
is designed for covalently labeling biomolecules under mild conditions and
physiological buffers. The size of the gold cluster and number of gold atoms
forming a cluster in the Nanogold reagent (~67 Au atoms) is between the smaller
Undecagold (0.8nm, 11 Au atoms) and the larger collidal gold (10nm) reagents
(Hainfeld and Powell 2000). This enables Nanogold to be visualized directly by
transmission electron microscopy (TEM), while reducing the non-specific
adsorption characteristics of larger, colloidal gold.
We were able to efficiently link monomaleimido nanogold to rhodopsin
using methods developed for fluorophore maleimides. The main differences were
a twofold higher rho concentration was used in the nanogold labeling reaction
compared with fluorophores (Method 2.4), and the mixture was not shaken during
incubation. After purification of rho, the labeling stoichiometry was determined
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by comparing the twin absorbances of nanogold at 280nm (280= 2.25 x 105
M-1cm-1) and 420nm (420= 1.12 x 105 M-1cm-1) with the difference spectrum of
rhodopsin. Using our labeling method, we obtained 0.8–0.9 nanogold per rho. We
assumed that Cys 316 would have been modified at these labeling ratios, similar
to fluorophore labeling experiments (Method 2.3). We reasoned that the larger
size of the nanogold gold cluster, compared to a fluorophore molecule, may
preclude its accessibility to the other Cys residues. The labeling ratio was further
checked by negative stain electron microscopy using dilute NG-rho (nanogold
labeled rho) samples and 1 NG-rho-NABB on the grid.
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4.3

Discussion

The sulfhydryl groups of bovine rhodopsin have been reported to exhibit
clearly different reactivity/accessibility upon treatment with SH reagents (De Grip
and Daemen 1982). The differences depend on the following conditions1. Type of reagent used.
2. The microenvironment of rhodopsin.
3. Illumination condition of rhodopsin.
In this case, we chose to label rhodopsin by using only maleimide
functionalized fluorophores. The fluorophores have different chemical structures
which would affect the hydrophobicity of the probes as well as its size. Both these
factors could control the accessibility of the probes to the cysteine residues on the
cytoplasmic side. The microenvironment of rho in all cases was chosen to be the
native ROS membranes. It is possible that the phospholipid headgroups of the
ROS also play a part in modulating accessibility of the probes to Cys 140 which is
closer to the lipid headgroups than Cys 316. Only very small, hydrophobic
reagents like methylmercury iodide, used at 90-fold molar excess over rho can
modify all cysteines in rhodopsin under similar conditions (Daemen, Van Breugel
et al. 1976).
The stoichiometry profile of the maleimide probes to the cysteines in rho
presented in this chapter is strictly dependent on the presence of a lipid bilayer.
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When rhodopsin is solubilized in detergents, more cysteines were available for
reaction with the probes (De Grip and Daemen 1982). The relative reactivity
difference between Cys 140 and Cys 316 may be diminished due to the more
disordered character of detergent micelles or detergent-induced changes in protein
conformation. Interestingly, it has been reported that the reactivity difference
between cysteines is maintained in digitonin, which forms rigid micelles where
detergent-lipid exchanges are minimal (Hong and Hubbell 1973).
Since the labeling reactions are carried out on ROS, care should be taken
to protect the cysteines from air oxidation, particularly since the ROS contains a
large proportion of unsaturated membrane lipids. The ROS was therefore flushed
with Argon to keep the sulfhydryl groups in a reduced state and remove traces of
reactive oxygen species, and EDTA containing buffers were used to chelate traces
of heavy metals. Maleimides start to react slowly with amino groups above pH 7,
therefore the pH was kept between 6 – 7 using a buffer that is not temperature
dependent (in this case, HEPES or sodium phosphate). Temperature and time of
the reaction are very highly correlated in these reactions. Below 20°C, reaction
rates with hydrophilic reagents decrease considerably and above 30°C, thermal
stability of rhodopsin is not enough for long incubations.
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5.0
Studies on Rhodopsin Monomers and Dimers
Incorporated into NABBs

5.1

Introduction

G protein-coupled receptors (GPCRs) are excellent examples of allosteric
proteins (Huber and Sakmar 2008). Knowledge about the functions of GPCRs and
biological processes governing their regulation has been increasing at an
accelerated rate. One of the aspects that can be reconciled with the allosteric
nature of many GPCRs is their ability to form homo- and heterodimers and higher
oligomers. For example, hetero-dimerization between two isoforms of the
GABAB receptor has been shown to affect cell-surface localization (MargetaMitrovic, Jan et al. 2000). Co-immunoprecipitation techniques have been used in
reports of receptor homodimerization in the case of metabotropic glutamate
receptor (Romano, Yang et al. 1996) and 2-adrenergic receptor (Hebert, Moffett

Material in this chapter has been previously published in: Banerjee S, Huber T, Sakmar TP. (2008)
Rapid Incorporation of Functional Rhodopsin into Nanoscale Apolipoprotein Bound Bilayer
(NABB) Particles. J. Mol. Biol. 377(4): 1067-81.
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et al. 1996) whereas cross-linking and bioluminescence resonance energy transfer
(BRET) have been used in reports of oligomerization of dopamine D2 (Guo,
Urizar et al. 2008). Most of the convincing reports of GPCR dimerization have
dealt with family C GPCRs (section 1.1). Even in these cases, the functional
consequences of a GPCR dimer towards G protein coupling, in a system free of
accessory proteins, is not known.
For rhodopsin, a prototypical family A GPCR, a wide variety of assays
have been applied by a number of research groups to determine whether
rhodopsin exists as a monomer or a homo-dimer/ higher oligomers, similar to
other known GPCRs in the native state (Fotiadis, Liang et al. 2003; Jastrzebska,
Maeda et al. 2004; Chabre and le Maire 2005; Kota, Reeves et al. 2006).
Attempts towards answering the question of whether rho dimerization is required
for transducin signaling has not led to a consensus, primarily because it has not
been possible to isolate rhodopsin monomers and dimers in a native-like welldefined environment that is free from interference of accessory proteins, yet
tenable for biochemical assays. In this chapter, we describe the first
demonstration of a novel single-particle electron microscopy imaging technique,
coupled with ensemble biochemical assays, to probe G protein activation rates by
rhodopsin monomers and dimers isolated in a nanoscale native-like membranemimetic systems, called NABBs (Chapter 3). We considered not only the
oligomeric state, but also the relative orientation of two rhodopsins when they are
incorporated in a NABB. We demonstrate that monomeric rhodopsin is sufficient
for efficient activation of transducin, and infer the limits of G protein activity that
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a putative physiological rhodopsin dimer may have. Defining the interaction of a
G protein with the monomer or the oligomerization interface of a GPCR, in terms
of catalytic center activity of the GPCR, could offer new pharmacological targets
that modulate receptor dimerization without interfering with critical GPCR
signaling pathways.
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Figure 5-1. Gel-filtration Chromatography of Rho-NABBs

Gel-filtration chromatography of rhodopsin-NABBs made by
Extracti-Gel D mediated detergent removal (Materials and Methods) using
Alexa-488 labeled zap1Q26C, LRB-DOPE doped POPC and Atto-655
labeled rhodopsin on a Superose 6 10/30 column using an Akta Explorer
10

FPLC

system.

0.1rho/NABB.

The

Absorption

incorporation
at

three

ratio

was

wavelengths

approximately
was

recorded

simultaneously: 280nm (protein absorbance), 570nm (LRB-DOPE
absorbance) and 650nm (Atto 655 rho absorbance) indicating elution of
total protein, lipid and rhodopsin from the column, respectively. (Top)
Eluted fractions were analyzed by loading equal volumes on a NuPAGE
4-20% Bis-Tris gel run with SDS-MES running buffer. SDS-PAGE was
followed by fluorescence detection using a Typhoon 9400 gel scanner.
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Figure 5-1. Gel-filtration Chromatography of Rho-NABBs
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Table 2. Stoichiometry of Components for NABB Formation
Rho / NABB

Rhoa

zap1b

POPCc

OGd

Cholatee

sample

(μM)

(μM)

(mM)

(mM)

(mM)

2 rho / NABB

80.0

80

3.3

51.0

34.8

1 rho / NABB

40.0

80

4.6

51.0

34.8

0.1 rho / NABB

4.0

80

5.8

51.0

34.8

0.01 rho / NABB

0.4

80

6.0

51.0

34.8

0 rho / NABB

0.0

80

6.0

51.0

34.8

(a) Rhodopsin was purified from bovine ROS using ConA-Sepharose affinity
purification and stored as 400mM stock in 1.5% OG. (b) Zap1 (hexa-histidine
tagged zebrafish apo A-I construct) was purified from E. coli using Ni-affinity
and gel-filtration chromatography and stored as 0.6mM stock. (c) POPC was
doped 1:100 with LRB-DOPE and stored as 13.1 mM stock in 1% sodium
cholate. (d, e) OG and sodium cholate were stored as 10% (w/w) stocks in water.
All components were stored at -80oC and thawed on ice before mixing. The
components were vortexed and incubated at room temperature for 30 min prior to
detergent removal either dialysis or Extracti Gel D in buffer T (Materials and
Methods).
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Figure 5-2. Affinity Purification and Spectroscopic Characterization
of Rho-NABBs

(A) Ni-NTA purification of a 1rho/NABB sample made with Atto655 labeled rhodopsin and Alexa-488 labeled zap1Q26C. The sample was
eluted with 10mM EDTA. (B) UV-visible spectra of Ni affinity purified
rhodopsin-NABBs made with different starting stoichiometries of
rhodopsin : zap1 with POPC stoichiometry adjusted accordingly (see
Table 2). Zap1 is His tagged and the NABBs are purified by the Ni
affinity purification. Spectra were normalized to unit absorbance at
280nm.
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Figure 5-2. Affinity Purification and Spectroscopic Characterization
of Rho-NABBs
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5.2

Results

5.2.1 Characterization of Rhodopsin Incorporation into NABBs

Dialysis (Method A) quantitatively removes detergents but can only be
used efficiently for detergents with relatively high CMC values. We used a
detergent removing gel, Extracti-Gel D (Pierce Biotechnology, Rockford, IL) to
remove detergents with comparatively low CMC values and to accelerate the rate
of NABB formation. The rate of detergent removal is expected to affect the
pathway of discoidal self-assembly and the particle size distribution (Rigaud,
Pitard et al. 1995). NABBs formed using Extracti-Gel D formed sharper gelfiltration profiles compared to detergent dialysis. Fig. 5-1 shows gel-filtration of
rho-NABB complexes made with Alexa-488 conjugated zap1Q26C, lissamine
rhodamine B sulfonyl DOPE (LRB-DOPE)– doped POPC and Atto-655 labeled
rhodopsin where the starting reconstitution stoichiometry was 1 rho per 10
NABBs. We used different starting molar ratios of rhodopsin to zap1 and POPC
(NABB components) to form NABBs and subjected them to small-scale batch
purifications using Ni affinity (Fig. 5-2 A). The unbound fraction contains
rhodopsin in vesicles and/or aggregates. Fig. 5-2 B shows the UV-visible spectra
of rho-NABBs made with different rhodopsin concentrations at a constant zap1
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concentration after Ni affinity purification. The final A500:A280 ratios are in good
agreement with the initial stoichiometries of the reactions, indicating that
rhodopsin incorporation in NABBs is efficient and controllable.
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Figure 5-3. FRET between Multiple Rhodopsins in a NABB

(A) FRET emission profiles of Alexa-647 labeled rhodopsin in
samples containing an equal mixture of Alexa-546 rho (Rd) and Alexa647 rho (Ra), with decreasing rho/NABB ratios. In each NABB formation
reaction, the rho concentration was constant and the relative proportion of
POPC and apo A-I were increased. 10nM rho in NABBs was used in the
cuvette for FRET measurements. The data are normalized to donor
(Alexa-546) emission. (B) Ratio of Alexa-647 emission to Alexa-546
emission calculated from (A). The red bar corresponds to a 2 rho/NABB
ratio and the blue bar to a 1 rho/NABB ratio. (C) FRET emission profiles
of Alexa-647 labeled rho in samples containing similar amounts of lipids
(POPC) as in (A) but with no apo A-I. (D) Ratio of Alexa-647 emission to
Alexa-546 emission calculated from (C). The color of the bars correspond
to the emission profile of the sample in (C).
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5.2.2 FRET between Multiple Rhodopsins in a NABB

To determine whether rhodopsin forms constitutive dimers in a detergent
solubilized form, we used increasing stoichiometry of NABB components (lipids
+ apo A-I) at a specific rho concentration in an attempt to form reactions where a
2 rho/NABB would be able to get ‘diluted’ out into 1 rho/NABB. We wanted to
test whether the 2 rhodopsins stay in a single NABB when given the possibility of
partitioning into separate NABBs. If rhodopsin had a strong, constitutive tendency
to dimerize, it would not dissociate from the other rhodopsin in detergent, or
when the detergent is removed to form NABBs. To test for rho dimerization, we
carried out Fluorescence Resonance Energy Transfer (FRET) experiments
between rho labeled with a donor fluorophore (Alexa-546) and rho labeled with
an acceptor fluorophore (Alexa-647) mixed in equimolar ratio in the NABB
formation reaction. Details about labeling and characterization of labeled
rhodopsin are given in the preceding chapter. The Förster radius of the Alexa-546
– Alexa-647 pair has been reported to be 6.8nm (Molina, Barrera et al. 2006). If
two rhodopsins with different labels were farther than 6.8nm apart from one
another, a decrease in the emission signal of the acceptor fluorophore (therefore
the FRET index) would be seen. The average diameter of a NABB is 10nm and
since the rhodopsins were reconstituted into NABBs from a detergent-purified
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state, a decrease in FRET index would also imply that the rhodopsins have been
incorporated into distinct NABBs.
We observed a decrease in FRET between rhodopsins in reactions that
contained increasing amounts of lipids and apo A-I compared to rho, as shown in
Fig. 5-3. A sharp decrease in FRET was seen when the NABB stoichiometry is
increased to accommodate 1 rho per NABB. Increasing the amount of unlabeled
rhodopsin in the reaction, while keeping the relative ratio of lipids and apo A-I
constant (corresponding to 2 rho/NABB) also showed a similar drop in FRET
index.
The FRET data indicate that 2 rhodopsins do not constitutively dimerize
when solubilized and purified in 1.5% octylglucoside containing buffer. When the
ratio of lipids and apo A-I is increased such that the rhodopsins may either stay in
the same NABB (maintain FRET) or distribute in separate NABBs (lose FRET),
the rhodopsins tend to distribute into separate NABBs. A vesicle control was
performed under similar rho and POPC concentrations but with no apo A-I added.
The drop in FRET in vesicles is seen due to rhodopsin dispersion due to
increasing lipid:rho ratio. Notably, the FRET values in vesicles are much higher
than in NABBs, even though the same rho concentration was used in the cuvette
in both experiments. The higher values are likely to be because of rhodopsin
aggregates in vesicles where one donor may transfer energy to more than one
acceptor in its vicinity. Since the Förster radius of the fluorophore pair (6.8nm) is
larger than the thickness of a typical phospholipids bilayer (5nm), we expect
efficient energy transfer to occur even if the 2 rhodopsins are incorporated anti-
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parallel to one another, both in NABBs and in vesicles. Using the Alexa-546 –
Alexa-647 fluorophore pair and ensemble FRET measurements, we were able to
determine proximity of the rhodopsins within 6.8nm but not the ‘sidedness’ of
incorporation of the rhodopsins.
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Figure 5-4. Electron Microscopy of Rho-NABBs

(A) (Top) Nanogold-labeled rhodopsin in 2 rho-NABB samples
imaged under negative stain in 0.5% uranyl acetate (UA). (Bottom)
Histogram of number of nanogolds per NABB in 816 NABB particles
chosen for analysis. 2 nanogold labels were visible in about 70% of the
particles. (B) Single particles of 2 or 1 nanogold labeled rhodopsinNABBs (NG-rho-NABBs) selected from nanogold labeled 2rho-NABB
and 1rho-NABB EM images. Nanogold densities in the NABB are
indicated with arrows. Outer edge of each box is 20nm in scale. (C) (Top)
Gel-filtration of 2Fab-rho-NABB complexes on a Superose 6 10/30
column. The peak of 2rho-NABB is shown for comparison. (Bottom)
Electron micrograph of 2Fab-rho-NABB shown under negative stain
conditions using 1% UA. (D) Representative set of single particles
obtained by epitope mapping of rhodopsin in NABBs using Fab. (Top)
Single particles of 2Fab-rho-NABB grouped into anti-parallel and parallel
orientation of rhodopsins in a NABB. A central ‘hole’ is clearly visible in
the Fab fragments consistent with electron micrographs of Fab particles
(Boisset, Radermacher et al. 1993). Orientation of Fab particles with
respect to the central NABB density is depicted in a cartoon representation
below each particle. Outer edge of each box is 30nm in length. (Bottom)
Relative proportion of anti-parallel and parallel rhodopsins in 2Fab-rhoNABB samples determined by visual classification of Fab density with
respect to NABB density from single particles of 2Fab-rho-NABB.
Cartoon representations of the orientations of the particles on the grid
considered for the analysis are shown on the y-axis. Representation a
depicts anti-parallel rhodopsins in NABBs that are observed with the label
on rhodopsin in a staggered or perpendicular position to the NABB
density. Representation b depicts 2 rhodopsins in a parallel orientation.
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5.2.3 Determination of Orientation of Multiple Rhodopsins in a NABB

In order to visualize the incorporated rhodopsins in NABBs, rhodopsinspecific labels with no cross-reactivity with the lipid or apolipoprotein in the
NABB were used. Rhodopsin was labeled site-specifically with nanogold and
imaged by negative stain EM at very dilute rho-NABB concentrations (Fig. 5-4 A
upper panel). The defocus used to image nanogold was typically less than the
defocus used to visualize proteins (Hainfeld, Powell et al. 2002). At optimum
underfocus values, the nanogold densities are clearly visible as high-density
structures together with NABBs that appear as low-density structures over the
background. Single particles were selected from individual micrographs using a
semi-automatic selection (‘boxing’) procedure using the ‘Boxer’ software, part of
the EMAN 1.7 suite of applications (Lüdtke, Baldwin et al. 1999). The nanogold
labeled rho-NABBs were tenable to statistical analysis by counting the number of
nanogolds per NABB. As shown in Fig. 5-4 A lower panel, more than 80% of the
selected particles had at least two rhodopsins and approximately 70% of particles
contained exactly two rhodopsins. 2 rho-NABBs and 1rho-NABBs can be clearly
identified by the nanogold density (shown by arrows, Fig. 5-4 B) in the
representative images. Thus, EM images may be used as further proof of
stoichiometry of rhodopsin incorporation into NABBs.
In order to determine orientation of multiply incorporated rhodopsins, we
chose to image rho-NABBs as a macromolecular assembly with anti-rhodopsin
Fab fragments bound to the C-terminus of rhodopsin in NABBs. We confirmed
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the formation of a stable 2Fab-rho-NABB complex by FPLC (Fig. 5-4 C upper
panel). The EM image of the macromolecular complex with 1% UA staining is
shown in Fig. 5-4 C lower panel. We propose that the NABBs are an effective
tool to image complexes of transmembrane receptors with associated signaling
molecules.
We analyzed Fab labeled rho-NABBs to ascertain the relative orientation
of two rhodopsins in a single NABB. In the case of Fab labeled particles, only
those particles were analyzed which have the NABB density approximately
perpendicular to the plane of the grid in order to be able to be able to discern the
Fab density which would be perpendicular to the characteristic NABB ‘discoidal’
density. The set of selected particles were subjected to visual inspection and
classified into either anti-parallel or parallel from the relative orientation of
nanogold or Fab density with respect to the central lipoprotein density. We
analyzed single particles picked from high defocus ( 3μm) images of 2Fab-rhoNABB particles to classify the orientation of the C-termini of the two
incorporated rhodopsins with respect to each other. For clarity, we chose only
those particles where the zap1 belt was oriented perpendicular to the plane of the
grid as these particles were the ones where the Fab positions could be detected
unambiguously with respect to the belt (Fig. 5-4 C lower panel). Analysis of
single particle images from Fab labeled 2rho-NABBs show that approximately
half of all the NABBs containing two rhodopsins contained the rhodopsins in an
antiparallel orientation with respect to each other (Fig. 5-4 D).

130

Figure 5-5. Thermal Stability of Rho-NABBs
Rho-NABB samples were made by detergent removal using
Extracti-Gel D (Method 2.15). The samples were Ni affinity purified
before analysis. Thermal stability of rhodopsin in various environments as
indicated determined by UV-vis difference photobleaching spectroscopy.
Each data point represents the average of three independent experiments.
Note that rhodopsin reconstituted in NABBs has similar stability as in
native ROS.
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5.2.4 Thermal Stability of Rho in NABBs

We compared thermal denaturation of rhodopsin in NABBs with
rhodopsin in ROS and detergents commonly used for rhodopsin biochemistry.
Thermal denaturation of rhodopsin occurs at a higher threshold temperature when
it is in rod disc membranes compared with detergent (Hubbard 1958; Knudsen
and Hubbell 1978). We observed that the denaturation temperature of rhodopsin
in NABBs is similar to rhodopsin in ROS (Fig. 5-5). The data indicate that
increasing the hydrophobic chain lengths of detergents (OG to DM), and
substituting the non-ionic head group (OG or DM) by the zwitterionic head group
of phospholipids (in NABBs or ROS membranes) both lead to substantial increase
in thermal stability. There seems to be a slight decrease in the denaturation
temperature when two rhodopsins inhabit a NABB compared to a single
rhodopsin per NABB and this decrease may reflect the difference in the number
of POPC molecules surrounding the rhodopsins and/or packing defects of the
lipids in the reduced space between rho and apo A-I. The stoichiometry at the
start of the self-assembly of the two rho per NABB particle has only 42 lipids
surrounding each rhodopsin (21 per leaf of the bilayer). While this number of
lipids may be comparable to the number of lipids surrounding rhodopsin in ROS
(Miljanich and Dratz 1982), it is only 35% of the 116 lipids surrounding
rhodopsin in a one rho/NABB case. The remarkable thermal stability of
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rhodopsin(s) in a NABB indicate that a minimal amount of lipids surrounding
rhodopsin is sufficient to preserve its conformational state and thermal stability
may not depend upon long range lipid interactions.
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Figure 5-6. Meta-II Decay and Opsin Regeneration

(A) Meta-II decay kinetics of one or two rhodopsins in NABBs
probed by Trp fluorescence increase as a function of time after bleaching.
Excitation wavelength 295nm, emission wavelength 330nm, integration
time 2 s. Data were fit to a pseudo first-order kinetics to determine the
half-life times of Meta-II decay. Values are averages of three independent
experiments. (B) Regeneration of opsin in NABBs (1 opsin per NABB)
probed by absorbance spectroscopy at 520nm. Absorbance was recorded
in 3 s intervals with an integration time of 1 s. Opsin formed by
photobleaching a 1rho-NABB sample (Method 2.21) was regenerated by
stoichiometric amount of 11-cis-retinal dissolved in empty NABBs (red
curve). Addition of 11-cis-retinal to empty NABBs is also shown (black
curve). The regenerated rhodopsin in NABBs was stable to treatment with
hydroxylamine and could be photobleached.
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5.2.5 Meta-II Decay and Regeneration of Opsin in NABBs

Meta-II decay of rhodopsin was followed by monitoring the change in Trp
fluorescence to determine the Meta-II decay kinetics of rhodopsin(s) incorporated
in a NABB. We found that the Meta-II intermediate in one rho-NABBs has a halflife of 17 min and Meta-II in two rho-NABBs has a slightly longer half-life of 20
min (Fig. 5-6 A). These values correlate with our data showing differences in the
fraction of deprotonated Schiff base formed upon actinic light exposure and are in
good agreement with previous reports of rhodopsin Meta-II decay assays (Heck,
Schädel et al. 2003; Jastrzebska, Maeda et al. 2004).
Opsin-NABB formed after Meta-II decay of rhodopsin was able to
regenerate rapidly and quantitatively in the presence of stoichiometric amounts of
11-cis-retinal (Fig. 5-6 B). Absorbance at 520nm was not affected by the
absorption peak of free retinal (378nm) or nonspecific Schiff base formation. The
rapid regeneration of opsin in NABBs compared with opsin in DM is probably a
result of the dramatic difference in the partial volume fraction of the lipidic
environment. A recovery of the characteristic difference spectra and lack of
hydroxylamine sensitivity under conditions minimizing photobleaching implies
that the added 11-cis-retinal forms a specific, protonated Schiff base linkage at
Lys-296 of opsin to form regenerated rhodopsin. Photobleaching the sample in the
presence of hydroxylamine greatly accelerates the decay of Meta-II. In the
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presence of the deprotonated Schiff base form of retinal, hydroxylamine leads to
the formation of a stable retinal oxime, a phenomenon that efficiently sequesters
the chromophore out of the opsin.
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Figure 5-7. Transducin Activation by One and Two Rho-NABBs

The rho-NABB samples were 1D4 affinity purified to remove
‘empty’ NABBs from interfering in the assay. Transducin activation by
one and two rhodopsins per NABB probed by Trp fluorescence. 10nM
rhodopsin(s) in NABB were photobleached in the presence of 100nM
holotransducin and non-hydrolysable GTP analog (GTP-S). Fluorescence
change of transducin due to 1rho-NABB (red curve) and 2rho-NABB
(blue curve) and empty NABB (black trace) is shown. The rates are
averages of three independent experiments.
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5.2.6 G protein Activation by Rhodopsin Monomers and Dimers

We measured the rates of transducin activation by rho-NABBs containing
predominantly either one or two rhodopsins per particle (Fig. 5-7). The data were
fit to an exponential of the form:
y=a1a2 ekx
with rate constant k. 1rho-NABB gave an apparent pseudo first-order rate
(1)
(1)
) of 6103 s1 and the 2rho-NABB sample gave a value ( kobs
) of
constant ( kobs

3103 s1. Since both samples contain the same rhodopsin concentration, the
number of catalytic centers for transducin activation is the same in the monomers
and dimers. If the dimers are a mixture of N different equally probable species
and only one of them is active, then the activity of this species is N-times the
activity of the monomer. The maximum activity of the parallel (physiologically
relevant) rho dimer may thus be calculated by assuming that only the parallel
dimer is responsible for the observed transducin activity. As suggested by EM
imaging, N equals two, and considering only the parallel dimer to be active, the
catalytic center activity (Segel 1993) of the dimer is same as that of the monomer.
Consequently, the dimer is equally efficient in activating transducin compared
with the monomer.
The statements above may be rationalized further by comparison of
transducin activation by rhodopsin in monomer and dimer form assuming it to be
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an enzyme-catalyzed reaction between rho (enzyme) and transducin (substrate).
Catalytic efficiencies of two enzymes may be compared by the ratio kcat K m for
the two enzymatic reactions. This ratio is also called the specificity constant and it
is an apparent second-order rate constant with the units M1s1 (Nelson and Cox
2004). The Turnover Number ( kcat ) may be specified as Molecular Activity or
Catalytic Center Activity, depending on the definition of enzyme concentration
(Segel 1993). Molecular Activity is defined as the number of moles of substrate
transformed per minute per mole of enzyme. Catalytic Center Activity is defined
as the number of moles of substrate transformed per minute per mole of active
subunit or catalytic center. In the following derivations, we adopt the Catalytic
Center Activity convention, since it has been hypothesized that a rho dimer
interacts with a single transducin (Filipek 2005). The observed pseudo first-order
rates of transducin activation are the products of

kcat K m and the rhodopsin

concentration.

The observed rate of transducin activation by the rhodopsin monomer and
dimer may be considered proportional to the concentration of rhodopsin in the
samples according to the following mathematical relations:

N

k

(1)
obs

=  k i(2)c i

(1)

i=1
N

N

c 0 =  c i = c 0  pi
i=1

(2)

i=1
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where,
(1)
is the observed pseudo-first order rate constant of rho-NABBs for transducin
kobs

activation,

ki(2) is the second-order rate constant of ith species of rho-NABBs for transducin
activation,
c i is the concentration of rhodopsin in the ith species of rho-NABB,
c 0 is the total concentration of rhodopsin in rho-NABB,
pi is the probability of occurrence of the ith species in a rho-NABB sample, and

N is the total number of species possible in each rho-NABB sample.

Consider two different cases of distribution of rhodopsin in rho-NABBs:

Case 1: N species are equally probable and all N species are equally active
(homogeneous case).
pi = 1 N

k (2) = k1(2) = k2(2) = ... = kN(2) > 0
N

k

(1)
obs

= c 0  pi k i(2)
i=1

(1)
kobs
= c 0N

k (2) =

(1)
kobs
c0

1 (2)
k
N
(3)

143

For rho monomer in 1rho-NABB (mon), only 1 species exists, thus N=1 (Case 1)
(2)
kmon
=

(1)
kobs,mon
c mon

(4)

From our experimental observations:
The same rhodopsin concentration is present in the dimer (dim) and monomer
(mon) samples:
c dim = c mon

Transducin activation rate of rho dimer is half of that of the monomer:

1 (1)
(1)
kobs,dim
= k obs,mon
2
For rho dimer in 2rho-NABB, two species exist, thus

N =2

Assuming both species in the dimer are equally active, from Eqn. (3) and (4) we
get:
(2)
kdim
=

(2)
kdim
=

(1)
k obs,dim
c dim
1
2

(1)
k obs,mon
c mon

(from exp. observations a and b)

1 (2)
(2)
kdim
= k mon
2

(5)

Thus in this case, the dimer is half as active as the monomer.
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Case 2: N species are equally probable and only one out of the N species is active.
pi = 1 N

k1(2) > 0
ki(2) = 0 for i > 1
N
(1)
kobs
= c 0  pi k i(2)
i=1

(1)
kobs
= c0

1 (2)
k1
N

k1(2) = N

(1)
kobs
c0

(6)

Assuming only the parallel (physiological) dimer is active (Case 2), we get:

k

(2)
dim

(1)
k obs,dim
=N
c dim

k

(2)
dim

(1)
k obs,dim
=2
c dim

(from exp. observation c)

k

(2)
dim

(1)
 1 k obs,mon

2
= 2

 c mon 

(from exp. observations a and b)

(2)
(2)
kdim
= k mon

(7)

Thus in this case, the active dimer has the same activity as the monomer.
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The rationale for using N may be generalized further. It has been reported
that a rhodopsin molecule may have three oligomerization interfaces and only one
of them form the ‘true’ rhodopsin dimer physiologically (Liang, Fotiadis et al.
2003; Suda, Filipek et al. 2004). Each oligomerization interface will lead to a
distinct dimer where one rhodopsin may be considered to be rotated in-plane with
respect to the other (see Fig. 1-4). These dimers may or may not be active towards
transducin. To arrive at the maximum activity of the ‘true’ dimer, we assume that
only the ‘true’ parallel dimer is active in a population of anti-parallel and parallel
(N=2) and three sub-populations of parallel dimers (N=6). The ‘true’ dimer will
then have 3-times the catalytic center activity of the monomer. If any of the
subpopulations are active towards transducin, then the ‘true’ dimer will have a
correspondingly lower activity, until all the subpopulations have equal activity
and the activity of the dimer becomes equal to the monomer.
In conclusion, we propose that the rhodopsin dimer in a lipid environment
does not have dramatically higher activity compared with rhodopsin monomer as
reported in detergents (Jastrzebska, Fotiadis et al. 2006). Earlier experiments
performed in detergents which reported long-range rhodopsin oligomerization and
markedly higher activity toward transducin by these oligomers (Jastrzebska,
Fotiadis et al. 2006) are difficult to interpret since the detergent concentration
effects may explain some, if not all, observations (Ernst, Gramse et al. 2007). Our
experiments in NABBs do not suffer from this detergent concentration artifact
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and hence we can propose the upper and lower limits of the G protein activity of
the putative (physiologically relevant) rhodopsin dimer.
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5.3

Discussion

5.3.1 Characterization of Rhodopsin-NABBs

We have demonstrated a method of rapidly incorporating the prototypical
7-TM GPCR rhodopsin from a detergent purified state into a soluble, controllable,
nanoscale lipid bilayer at high efficiency using apolipoprotein A-I, which we
cloned from zebrafish. We have discussed a strategy for high-yield heterologous
expression, purification and site-specific labeling of zebrafish apo A-I (zap1,
zap1Q26C). Zap1 has favorable thermodynamics of interaction with POPC and
proceeds to interact with POPC via an increase in its -helical character (Chapter
3). A discoidal Nanoscale Apolipoprotein Bound Bilayer (NABB) is formed by a
self-assembly process between lipids and zap1 triggered by detergent removal.
Integral or peripheral membrane proteins present in the detergent mixture at a
certain concentration become incorporated into the NABB.
The enhancement of thermal stability of rhodopsin upon incorporation into
NABBs is particularly striking. Many GPCRs show time-dependent loss of
activity in detergents (Navratilova, Sodroski et al. 2005). Using our method of
rapid incorporation into the phospholipid matrix of NABBs, long-term exposure
to detergents may be avoided, thereby extending the resilience of the reconstituted
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GPCR for in vitro studies. Thermal stability of rhodopsin is likely to be enhanced
by shielding of the transmembrane hydrophobic area from water and satisfying
specific chemical interactions with phospholipids on the protein surface. Local
coupling of phospholipids to rhodopsin (Huber, Botelho et al. 2004; Soubias,
Teague et al. 2006) results in long-range curvature elastic deformations in a
bilayer membrane (Brown 1994), which influences the conformational energetics
of the Meta-I/Meta-II transition and rhodopsin oligomerization (Botelho, Huber et
al. 2006; Periole, Huber et al. 2007). Furthermore, we have demonstrated that the
NABBs may be utilized for isolating either one or two receptors in absence of
excess empty NABBs—a phenomenon that is not possible to achieve in detergent
micelles.

5.3.2 Single-Particle Analysis of EM Images

The negative staining technique in electron microscopy has the advantage
that the particles appear with high contrast, which enables a clear visualization of
Fab fragments on the edge of discoidal NABB structures. However, this technique
suffers from some shortcomings. A certain amount of flattening of the particles is
usually observed in negatively stained, air-dried samples. The extent of flattening
is lower in regions of higher concentration of the negative stain (Boisset,
Radermacher et al. 1993). Air drying and stain properties may cause aggregates of
the molecules on the grid and exaggeration of the particle sizes, which limits the
number of well-separated particles that can be obtained from a micrograph for
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analysis. While a visual classification was possible, the lipoprotein particles had
sufficient heterogeneity in shape to be intractable to more rigorous statistical
analyses. In the technique of cryo-EM, the molecules are entrapped in their
native orientation in a layer of vitreous ice. The densities measured in cryo-EM
reflect the projections of the biological material without any staining agent around
the particle. However, while using charged lipoproteins like NABBs made with
POPC as the lipid, the strong electron density of the lipid headgroups overwhelms
the densities of proteins that are not sufficiently separated from the lipid bilayer.
Cryo-negative staining may be an emerging technical improvement for imaging
lipoprotein particles. Embedding the sample in vitreous ice after negative staining
could reverse the strong electron density of the lipid headgroups under cryo-EM
conditions, and allow acquisition of medium to high-resolution structural data of
membrane proteins incorporated in these discoidal lipoprotein particles.
An important unanswered question from previous work on putative rho
dimers was the relative orientation of the two rhodopsins incorporated in a
discoidal lipoprotein. Ensemble fluorescence based proximity methods (like
FRET) could not be used since the properties of most commercially available
fluorophores do not allow a clear resolution between parallel and anti-parallel
dimers in a mixed population. We chose to undertake EM imaging followed by
single-particle selection from the micrographs. We experimented with two
complementary labeling techniques of rhodopsin which would enable us to
measure the stoichiometry of rho incorporation and the position of the C-termini
of rho when 2 rho were incorporated into a NABB. We chose previously
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characterized NABB densities in EM images to select particles for our analyses.
Our EM observations indicate that in approximately one-half of the NABBs with
two rhodopsins, the rhodopsins are oriented anti-parallel to each other. This ratio
was independent of whether the samples were prepared by dialysis or over
Extracti Gel D columns, indicating that the process of ‘rhodopsin scrambling’
does not depend on the rate of detergent removal. The anti-parallel orientation in
the 2Fab-rho-NABB (Fig. 5-4) had a profound impact when we attempted to
determine the structure of the complex using the ‘common lines’ algorithm of
single-particle averaging (Lüdtke, Baldwin et al. 1999), as seen in Appendix Fig
A. The barrel shape of the complex is due to the influence of Fab density above
and below the plane of the NABB. Averaging the Fourier Transform of the image
class averages by imposing a C6 symmetry axis perpendicular to the plane of the
NABB gives rise to a heavy ‘smear’ of density on both sides of the NABB.

5.3.3 Insights into G protein Activity of a Putative Rhodopsin Dimer
Compared to a Monomer

Dimerization of family A GPCRs, particularly rhodopsin, is still a matter
of intense debate (Chabre, Cone et al. 2003; Fotiadis, Liang et al. 2003;
Jastrzebska, Maeda et al. 2004; Ernst, Gramse et al. 2007). A key question in the
field is whether the rhodopsin monomer or putative dimer is the signaling unit for
G protein activation. Model systems used to address this question are receptors in
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detergent micelles, proteoliposomes, and recently, apo A-I stabilized phospholipid
bilayer particles. Using detergent micelles, it has been claimed that dimeric
rhodopsins have higher Gt activation rates than monomers (Jastrzebska, Maeda et
al. 2004; Jastrzebska, Fotiadis et al. 2006). However, others have pointed out that
the method is inappropriate to support the conclusions (Chabre and le Maire 2005;
Ernst, Gramse et al. 2007). Work with rhodopsin in proteoliposomes has shown
that dispersed rhodopsin is more active (Botelho, Huber et al. 2006). In line with
this observation, Whorton et al. showed, using 2-adrenergic receptor (2-AR)
reconstituted into HDL particles, that monomeric receptor is sufficient to activate
G protein (Whorton, Bokoch et al. 2007). However, their work cannot exclude the
possibility that receptor dimers may have substantially higher activity than
monomers. Using a similar approach, Bayburt et al. have used one and two
rhodopsins in Nanodiscs, and have concluded that dimerization is not necessary
for efficient coupling of rhodopsin to transducin (Bayburt, Leitz et al. 2007).
However, this conclusion is based on the assumption that two rhodopsins per
Nanodisc form a physiologically relevant, parallel dimer. Here we show, using
NABBs, that such structures formed with two rhodopsins contain a mixture of
parallel and anti-parallel dimers.
Together with the Gt activation results, and assuming that the parallel
dimer is inactive, it follows that the active dimer has the same catalytic center
activity as the monomer. As proposed in the rhodopsin “rows of dimers” model
(Liang, Fotiadis et al. 2003), a rhodopsin molecule may have three
oligomerization interfaces. If the parallel dimer consists of subpopulations of
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dimers using these dimerization interfaces then only a fraction (1/3) will contain
the postulated ‘true’ dimer. Consequently, the catalytic center activity of this
structure could be at most (assuming all other subpopulations to be inactive) 3times the activity of the monomer.
In a GPCR like rhodopsin which does not constitutively dimerize in
detergent, an accurate estimation of G protein activation rates due to the
physiological dimer can only occur when the correct dimeric interface between
the 2 rho in a NABB can be detected (for example, by using high-resolution EM
techniques). Our method presented here cannot conclusively determine the rate of
the putative physiologically relevant rho dimer. We proceeded by assuming that
the aforementioned dimer is a part of the mixture of rho configurations that we
detect using electron microscopy. Thus, we provide a conceptual model for the
possible limits of G protein activity of a GPCR dimer in a NABB compared with
a monomer.

5.3.4 Rho Dimerization is an Assay Dependent Phenomenon

We have offered proof in this chapter that rhodopsin does not form
constituitive dimers when reconstituted into NABBs from a detergent solubilized,
purified state. Our EM studies also show that any detergent-based in-vitro dimer
or oligomerization based functional assays must take into account the relative
orientation of the GPCRs, in order to be meaningful.
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What is the cause of the underlying artifacts associated with detergent
solubilized membrane proteins, specifically regarding their tendency to adopt an
anti-parallel orientation? One explanation takes the topological asymmetry of
biological membranes, and its subsequent disruption, into account. The
asymmetry of native membranes of membrane proteins is manifested by
differential distribution of phospholipids between the two leaflets of the bilayer.
The lipid arrangement provides the membrane proteins not only with maximum
interaction forces with phospholipids but also with additional stability of their
quarternary structure (Klingenberg 1981). After detergent solubilization, the
asymmetric environment of the membrane is lost, as the detergent forms a micelle
around the membrane protein. The uniform detergent may not allow a differential
binding of molecules to different parts of the protein. The absence of this
differentiation may cause instability of detergent-solubilized proteins, forcing
them to form an anti-parallel (non-physiological) orientation to satisfy the
hydrophobic interactions in their structure. A similar argument of satisfying
hydrophobic interactions between two rho monomers may be used to explain why
two rhodopsins incorporated in a NABB adopt an anti-parallel arrangement. If the
extent of hydrophobic contacts and other non-covalent forces in a physiologically
relevant, parallel rho dimer were sufficiently strong, it would have resisted the
need to reorient itself in detergent.
Rhodopsin reconstitution in asolectin produced self-associated, symmetric
oligomers (Mansoor, Palczewski et al. 2006). However, this phenomenon is not
unique to rhodopsin and seems to be a property of the lipid mixture comprising
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asolectin (24% saturated, 14% mono-unsaturated and 62% polyunsaturated) at a
certain lipid to protein ratio only which is not generally applicable to other lipids
(e.g- egg PC, POPC, DMPC) (Huang, Bayley et al. 1980; Niu, Kim et al. 2002).
Biophysical and Molecular Dynamics of rhodopsin with a range of lipids
(Botelho, Huber et al. 2006) (Periole, Huber et al. 2007), has shown that the
hydrophobic mismatch between lipid chains and the rhodopsin transmembrane
region, as well as local deformations in the bilayer thickness as a result of
accommodation of phospholipids to the hydrophobic and polar faces of
rhodopsin, drive rhodopsin aggregation. Finally, it has been proposed that some
experiments consisting of cellular overexpression of GPCRs may have
overestimated dimerization due to transient, non-specific protein contacts (James,
Oliveira et al. 2006). In our approach, we isolated and purified two rhodopsins in
close proximity (less than 10nm apart) using NABBs. However, this is possible
due to excess rho present during NABB formation (Table 2), and limited by the
diameter of a NABB.
Comparisons of dimerization potential of rhodopsin (and other family A
GPCRs) with GPCRs that are currently known to form strong dimers (Romano,
Yang et al. 1996; Kaupmann, Malitschek et al. 1998) and higher order oligomers
(Guo, Urizar et al. 2008) are often made in support of the rhodopsin dimer model.
However such comparisons are not strictly valid since most of the latter GPCRs
possess distinct structural elements that facilitate dimerization. These elements
include extended N termini, folded into distinct motifs, as well as extended Ctermini (Bockaert and Pin 1999; Bockaert 2003). The constitutive homo or
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heterodimers are often disulfide linked or associated with their large extracellular
domains which include the ligand binding site. These structural features and
phenomena have not been reported in rhodopsin.
Another major factor that tends to be overlooked in comparative reports
between rhodopsins and other GPCRs is the issue of GPCR trafficking to the cell
surface. For instance, in the case of one of the best known GPCR dimers, the
GABAB receptor, two isoforms GABABR1 (GBR1) and GABABR2 (GBR2)
dimerize to form the functional receptor (Jones, Borowsky et al. 1998;
Kaupmann, Malitschek et al. 1998; White, Wise et al. 1998). When the isoforms
are expressed alone in cells, GBR1 is retained intracellularly (Couve, Filippov et
al. 1998) while GBR2 is transported to the surface but cannot bind GABA or
initiate signaling (White, Wise et al. 1998). It is hypothesized that GBR2 acts as a
molecular chaperone that masks the ER retention signal of GBR1 using the Cterminal end thus allowing transport of the dimer to the cell surface in a functional
form (Margeta-Mitrovic, Jan et al. 2000). In contrast, rhodopsin is trafficked from
rod inner segments (site of synthesis) to mature rod outer segments (ROS) in the
retina using a specialized pathway involving a series of coordinated fusions
(Boesze-Battaglia 2000). This process of fusion is likely optimized for high
density of rhodopsins that is required for close to single-photon sensitivity to dim
light.
From our experiments, we deduce that dimerization of rhodopsin may not
be required for transducin activation. It is, however, interesting to speculate
whether oligomerization of other GPCRs has been an evolutionary process that
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may have led to fine-tuning of the G protein signaling rate in cells. A
computational study of possible dimeric interfaces of GPCRs using a chimeric
muscarinic M3 and adrenergic 2 receptor system predicts a parallel orientation of
the third intracellular loop (IL 3) in each monomer, with the orientation preserved
even across different putative dimerization interfaces (Gouldson, Higgs et al.
2000). This may have important functional consequences in terms of G protein
interaction with this domain. Interestingly, the arrangement of transmembrane
helices in the helix IV-V rho dimerization model (Fig. 1-4) does not appear to be
one of the several possible of the dimerization motifs presented.
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6.0
Chemokine Receptor 5 (CCR5) Incorporation and
Activity in NABBs

6.1

Introduction

Chemokine receptor 5 (CCR5) is a clinically important GPCR but only
limited experimental reports exist about its molecular mechanism in a purified,
cell-free state (Mirzabekov, Bannert et al. 1999; Stenlund, Babcock et al. 2003;
Navratilova, Dioszegi et al. 2006). The lack of information about CCR5
compared with other membrane proteins may be due to the inability to get high
amounts of CCR5 for purification and in-vitro studies. CCR5 requires unique
posttranslational modifications for function (Farzan, Mirzabekov et al. 1999),
which varies depending upon the cell type used for heterologous expression.
CCR5 also shows a marked loss of activity when purified in detergents
(Mirzabekov, Bannert et al. 1999). We have previously shown that rhodopsin
exhibits a significant increase in thermal stability when reconstituted into NABBs
(Banerjee, Huber et al. 2008). We reasoned that NABBs may be the ideal
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platform for in-vitro studies of CCR5 by providing the detergent-labile receptor a
stable, soluble, lipid environment for biochemical assays.
CCR5 has many known ligands (Rossi and Zlotnik 2000), but the most
well-characterized agonists are RANTES, MIP-1 and MIP-1. These ligands are
able to suppress HIV-1 infection in-vitro (Wilkinson 1996; Princen and Schols
2005). While RANTES is basic at physiological pH, MIP-1 and MIP-1 are
acidic under those conditions. However all three interact with CCR5. In-vitro
receptor binding and activation studies show a large overlap in receptor and
chemokine specificities. This effect is not echoed in-vivo according to gene
knockout and antagonist assays (Gerard and Rollins 2001; Proudfoot 2002).
Traditional methods of screening receptor activity use radiolabeled ligands or
nucleotide, which are hazardous, costly and cumbersome to use. We made use of
a recently developed fluorescent GTP analog (McEwen, Gee et al. 2001) to
design an assay that is able to detect ligand mediated G protein activation. The
ideas and methods presented in this chapter will enable us to answer pertinent and
long-standing questions about the effect of G protein on binding affinity of CCR5
ligands and differential activation of G proteins by different chemokines.
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Figure 6-1. Sandwich-ELISA Strategies used for Characterizing
CCR5-NABBs

Sandwich ELISA uses dual epitopes on the CCR5-NABB in a
high-throughput, antibody-based screening protocol. The two antibodies
are selected based on the assay performed. The fluorimetric quantitation is
made possible by a colorless substrate that is converted into a fluorescent
product by a catalytic reaction of Horseradish peroxidase (HRP) in the
presence of excess H2O2. (A) 2D7 / 1D4 ELISA. The capture antibody is
2D7, a conformation sensitive antibody to the extracellular side of CCR5.
The amount of correctly folded CCR5 bound to 2D7 is detected by
probing with HRP-tagged 1D4 antibody, which recognizes a linear epitope
engineered at the C-terminus of CCR5. (B) 6xHis / 1D4 ELISA. The
capture antibody is a hexa-histidine (6xHis) tag recognizing antibody that
binds to His tags present on zap1 which form NABBs. The amount of
NABBs containing CCR5 (or any other 1D4-epitope tagged receptor) is
detected by probing with 1D4-HRP antibody. (C) 1D4 / 6xHis ELISA.
Switching the order of antibodies in (B) results in an assay that estimates
the proportion of the total CCR5 in NABBs.
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CCR5-NABBs
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6.2

Results

6.2.1 Rapid Incorporation of CCR5 into NABBs

A stable cell line was established and used for the purpose of optimizing
incorporation of CCR5 into NABBs. HEK-293 cells were labeled with FITC
conjugated anti-CCR5 antibody and the highest expressing clone (R5-18) was
selected and amplified. Unlike rhodopsin, CCR5 does not have a characteristic
spectroscopic signal. Therefore, to characterize CCR5 incorporation into NABBs,
we first developed a high-throughput sandwich ELISA assay (Fig. 6-1). We
designed the screen to quantify both the correctly folded CCR5 in NABBs as well
as total CCR5 using different antibodies commercially available for CCR5 in
order to detect nanomolar concentrations of CCR5.
We were able to incorporate CCR5 in NABBs starting from cell-pellets
derived from 6-10 10 cm diameter (approx. 314 cm2 area) plates. The cells were
lysed in a mixture of lipids and detergents that has been reported to preserved
CCR5 stability (Navratilova, Sodroski et al. 2005; Navratilova, Dioszegi et al.
2006). The CCR5 fraction was enriched using 1D4-sepharose beads and the
buffer was exchanged to buffer H1 containing POPC/POPS and CHAPS.
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Figure 6-2. Gel-filtration of CCR5-NABBs

Gel-filtration chromatography of CCR5-NABBs made by ExtractiGel D mediated detergent removal (Method 2.24) using NBD-DOPE
doped POPC on a Superose 6 PC 3.2/30 column on an Akta Explorer 10
FPLC

system.

Absorption

at

two

wavelengths

was

recorded

simultaneously: 280nm (protein absorbance), 460nm (NBD-DOPE
absorbance) indicating elution of total protein and lipid from the column.
The eluted fractions were analyzed by sandwich ELISA, using 2D7 as the
capture antibody and 1D4-HRP as the probe. Since 2D7 is a conformation
sensitive antibody, the ELISA profile indicates the amount of correctly
folded CCR5 in the eluted fractions. The basal response was calculated
using empty NABBs, prepared under identical conditions and assayed on
the same ELISA plate at similar protein concentration.
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Figure 6-2. Gel-filtration of CCR5-NABBs
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The CCR5 was eluted with 1D5 nonapeptide, and purified zap1 was
added. Detergent removal from this solution was done by passing over an Extracti
Gel-D resin, yielding NABBs, as determined by a single peak in the gel-filtration
step (Fig. 6-2). Correctly folded CCR5 was detected in the fractions using ELISA
with 2D7 capture and 1D4 probing. 2D7 recognizes a split epitope on the
extracellular side of CCR5 when parts of the epitope are spatially close, and is
therefore considered to bind to the correct conformation of CCR5 (Khurana,
Kennedy et al. 2005).
The CCR5 elutes at the molecular weight region (retention volume)
characteristic of NABBs, as well as at higher molecular weight regions using a
Superose 6 column. The cumulative signal of CCR5 in fractions 2-4 is higher than
the CCR5 signal in fraction 5 (NABB peak). This distribution indicates that most
of the CCR5 may be incorporated in larger discs, or multiple CCR5 may have
been incorporated in the NABBs. The latter possibility is less likely given the
high NABB / CCR5 ratio used for NABB formation (>100:1), unless CCR5 forms
constitutive dimers in detergents used for cell lysis.
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Figure 6-3. Conformational Stability of CCR5 in NABBs

Conformational stability of the extracellular side of CCR5 after
exposure to different detergents was determined by a sandwich ELISA
using 2D7 and 1D4 (Fig. 6-1 A, Method 2.25). HEK-293 (clone 18) cell
aliquots were lysed using Buffer (20mM Tris pH 7, 150mM NaCl, 1mM
EDTA) supplemented with detergents (1% w/v) and lipids (1% w/v total
lipid) as shown at 4°C for 1 h. The samples were incubated at room
temperature for 30 min before loading on the 96-well plate. Sample 2 was
kept in a 95°C water bath immediately after lysis for 5 min, followed by
30 min room temperature incubation. Sample 7 was processed from a cell
aliquot lysed under conditions of Sample 1, followed by detergent removal
as described in Method 2.24 (Materials and Methods).
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Figure 6-3. Conformational Stability of CCR5 in NABBs

167

6.2.2 Detection of correctly folded CCR5 in NABBs

We optimized an ELISA protocol where the antigen (CCR5-NABBs) was
sequentially sandwiched between two antibodies recognizing specific, distinct
epitopes on the CCR5-NABB assembly. 2D7 is a monoclonal antibody that has
been shown to recognize a split epitope on the extracellular side of CCR5 only
when the epitopes are in proximity to each other (Wu, LaRosa et al. 1997;
Khurana, Kennedy et al. 2005), which would be the case in a correctly folded
form of CCR5. Heat denaturation abolishes 2D7 binding to CCR5, and the 2D7
binding may be competitively inhibited by chemokines. 1D4 monoclonal antibody
recognizes an engineered linear amino-acid sequence at the C-terminal tail of
CCR5. We measured the binding of CCR5-NABBs to 2D7 (capture antibody) as
an indication of correctly folded CCR5. The amount of CCR5 bound to the
capture antibody was measured by detecting the binding of the second antibody–
HRP-linked 1D4, and adding a fluorogenic HRP substrate in the microplate wells.
The sandwich ELISA data is shown in Fig. 6-3. Equivalent volumes were used
for each sample.
To measure total amount of CCR5 in NABBs, 1D4 antibody was used as
the capture antibody and HRP-linked hexa-histidine binding antibody (6H) was
used as the detection antibody to recognize the hexa-histidine tag on zap1. HEK
cells solubilized in buffer containing dodecyl maltoside (DDM), CHAPS and a
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1:1 (w/w) mixture of DOPC and POPC lipids gave the highest ELISA signal
(sample 1). Heat treatment of this sample, followed by thawing at room
temperature destroyed binding to 2D7 antibody (sample 2). Sample 2 served as a
negative control for this ELISA, since it shows that the final ELISA signal is due
to specific initial binding to 2D7, and not because of non-specific binding to the
microplate well. Heat denaturation of CCR5 destroys the native conformation of
the extracellular loops (including ECL 2) resulting in loss of binding to 2D7. We
also tested solubilization conditions where different detergents were used
(samples 3-6) at 1% (w/v) concentrations. At these concentrations, all the
detergents studied were above their CMC values. The samples were incubated for
30 min at room temperature. DDM was seen to be the best detergent for
stabilizing the 2D7 epitope, with a signal that was 65% of sample 1.
Reconstitution of a sample solubilized in conditions identical to sample 1 into
NABBs using POPC and zap1 (Method 2.24) gave a signal that was 92% the
signal of sample 1. The ELISA data implies that rapid incorporation of CCR5 into
NABBs preserves the native conformational state of the receptor. It should be
mentioned that there is likely to be a difference in the extent of antibody binding
by receptors in detergent and in NABBs. We expect the binding of receptor in
NABBs to be less than that of receptor in detergent micelles because of lesser
accessibility of the epitope to the antibody, and the charged phospholipids
headgroups. If this binding difference is considered, then the signal of sample 1
and sample 7 will be virtually identical.
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Figure 6-4. Ligand Mediated Activation of CCR5 in NABBs

CCR5 activation of G protein was measured by binding of a
fluorescently labeled nucleotide analog BODIPY-FL-GTPS. BODIPYFL-GTPS binds to activated G protein and undergoes an increase in
fluorescence quantum yield. The fluorescence increase of BODIPY-FLGTPS was measured using CCR5-NABBs with or without ligand. (A)
Change in BODIPY-FL-GTPS fluorescence using CCR5-NABBs and
different G protein components is shown in the absence or presence of
ligand (RANTES). Rhodopsin-NABBs and holotransducin were used as a
positive control. Gi1 -subunit (Gi1) was heterologously expressed and
purified from E. coli (Method 2.8.1). Holotransducin (Gt) was isolated
from bovine retinae (Method 2.5), and transducin beta-gamma subunits
(Gt) were derived from holotransducin (Method 2.6). Fluorescence
intensity was calculated relative to that of a mixture of G protein and
empty NABBs. (B) Specific RANTES mediated increase in G protein
activity derived from panel A.
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6.2.3 Ligand-mediated G protein Activity of CCR5 in NABBs

A fluorescent, non-hydrolysable, non-radioactive GTP analog was used to
measure guanine nucleotide exchange by the G-protein in the presence or absence
of ligand-stimulated receptor. The BODIPY-FL-GTPS (B-GTPS) nucleotide
undergoes an increase in fluorescence quantum yield upon binding to the Gprotein -subunit (McEwen, Gee et al. 2001). The fluorescence increase occurs
presumably due to de-quenching of the fluorophore from the guanine ring, which
occurs in the extended conformation of the nucleotide when it resides in the
nucleotide binding pocket. The maximum increase in quantum yield of B-GTPS
upon binding to Gi1 has been reported to be 3-4 times over B-GTPS alone.
Unlike (unlabeled) GTPS, binding of B-GTPS has been hypothesized to form
an intermediate activated state of Gt between the inactive and fully-activated
states (Ramachandran and Cerione 2004). The nucleotide may be used to follow
the steady-state enzyme kinetics of the G subunits (Jameson, Roof et al. 2005).
In this case, we adapted the reagent concentrations and reaction time to enable us
to monitor increase in fluorescence of B-GTPS in an end-point assay. The assay
was optimized using rhodopsin-NABBs and holotransducin.
CCR5 is known to couple to the Gi class of G-proteins (Cardaba, Kerr et
al. 2008). We observed efficient G-protein activation by CCR5-NABBs in the
presence of the heterotrimeric Gi protein, as well as holotransducin. Stimulation
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of CCR5 in NABBs by 50mM RANTES produced upto 30% enhancement of BGTPS binding to the G protein, compared with unstimulated CCR5-NABBs
(Fig. 6-4). The largest increase in BODIPY-FL-GTPS was seen when 
subunits from transducin were mixed in equimolar ratio with E. coli expressed
and purified Gi1. The E. coli expressed Gi1  subunit used in this experiment did
not contain post-translational modifications (prenylation or myristoylation) that
are present in native G subunits. The results indicate the requirement of a
heterotrimeric G protein to observe the activity of CCR5. The -subunit of the G
protein is mostly in contact with the cytoplasmic side of the GPCR. However,
CCR5 does not seem to couple efficiently with Gi alone. We noticed a
requirement of the  subunits for efficient activation of the G protein  subunit.
In our assay, the role of  subunits may be to increase the accessibility of the Gi1
 subunit to the NABB due to the lipid anchor present on the -subunit.
Isoprenylated peptides have approximately 10-fold higher affinity for lipids than
their unmodified versions (Silvius and l'Heureux 1994). The 1 subunit (present in
transducin) contains a farnesyl (15 carbons) modification at its C-terminus. Other
-subunits have geranygeranylations (20 carbons) at the same location
(Wedegaertner, Wilson et al. 1995). It is also plausible that the -subunits
modulate an increase in the receptor mediated GTP uptake by the -subunit by
affecting the conformational change in the G protein.
We detected B-GTPS uptake in the presence of unstimulated CCR5NABBs (Fig. 6-4 A). A certain basal level of constitutive GPCR activity is
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common for GPCRs in the absence of an inverse agonist (Bartfai, Benovic et al.
2004). Under the conditions of our assay, a 10-15% greater binding of B-GTPS
was seen in the presence of CCR5-NABBs without ligand compared with empty
NABBs alone. Samples with RANTES showed a significantly higher increase in
signal.

6.3

Discussion

6.3.1 A General Incorporation and Detection Strategy for Expressed
Membrane Proteins into NABBs

Unlike rhodopsin, CCR5 and other known GPCRs do not contain an
internal chromophore with which to accurately estimate their concentration in a
mixture of other proteins. We therefore chose to work in small volumes for
NABB formation (50 – 100 μL) and make the concentration of NABBs high
enough such that there are always excess of empty NABBs compared to
membrane proteins in that volume. Using this approach, we can approximate that
most, if not all, membrane proteins in the cell lysate will be incorporated into
NABBs. The GPCR containing NABBs were then isolated using immunoaffinity
purification. We have also refined this method by adding a short immunoaffinity
step for the GPCR prior to NABB formation. This modification enabled us to
work with larger volumes of lysate and higher concentrations of the GPCR, as
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well as do a convenient buffer exchange from the cell lysis buffer to the NABB
formation buffer while the GPCR was on the solid immunoaffinity bead support.
The method developed for rapid incorporation of CCR5 in NABBs may be
generalized to other membrane proteins that are expressed in cells at similar or
higher levels. The method is also scalable to larger volumes, using the same
strategies of cell lysis, initial enrichment, NABB formation, final purification, and
antibody-based characterization.
Conventional methods of characterization of macromolecular protein
complexes commonly involve SDS-PAGE and immunoblotting. In these methods,
any information about activity is lost and quantitation of the signal is difficult, and
relatively few samples may be analyzed simultaneously. We developed a
sandwich ELISA technique which may be easily adapted to different membrane
proteins in NABBs by using appropriate antibodies. The screening process was
adapted for a microplate due to which many conditions may be analyzed in
replicates in a rapid and quantitative way. We chose an antibody (2D7) that
recognizes the biologically relevant conformation of CCR5 in order to analyze the
amount of active receptor incorporated in NABBs. 2D7 has also been shown to
effectively compete with RANTES and gp120 from HIV for binding to CCR5
(Wu, LaRosa et al. 1997; Rossi and Zlotnik 2000; Zhang, Rao et al. 2007). This
property enables us to focus on those conditions that are most likely to yield
CCR5-NABBs which can be analyzed for relevant biological assays.
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6.3.2 G protein Activation by CCR5-NABBs

The presence of G protein may serve to modulate ligand affinity in the
GPCR, probably by making high-affinity sites accessible to agonist (Whorton,
Bokoch et al. 2007). In-vitro assays of small-molecules affecting ligand binding
to CCR5 in the absence of G proteins may not be accurate in predicting the invivo effects. A series of cell-based and membrane-based assays have determined
that CCR5 couples to both Gi as well as Gq class of G proteins (Mueller,
Mahmoud et al. 2006; Springael, de Poorter et al. 2007). Whether a CCR5
facilitated HIV infection involves G protein signaling by CCR5 is not resolved
(Gosling, Monteclaro et al. 1997; Kinter, Catanzaro et al. 1998). Further, CCR5
has been shown to interact with CD4 and CXCR4 in assays where HIV entry is
accompanied by either Gi or Gq signaling (Lin, Mettling et al. 2006; Harmon and
Ratner 2008). However, there have been no reports of assays of CCR5 with
purified G proteins. The BODIPY-FL-GTPS binding assay presented here is a
convenient and rapid method to assay for effector mediated G protein activation
using purified CCR5-NABBs with purified G proteins.
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7.0

Future Perspectives

7.1

Introduction

Nanoscale, water-soluble, well-defined lipid bilayer particles like NABBs
have tremendous potential in a variety of applications in spectroscopy, cellbiology and medicine. Based on work done by other groups on similar nanoscale
structures and membrane proteins, and our own data and experience, this chapter
presents the near and long term experimental approaches that will be made
possible using NABBs.

7.2

Novel Assay Development

7.2.1 Infra-Red Spectroscopy of Membrane Proteins

Fourier transformed infrared spectroscopy (FTIR) difference spectroscopy
is a widely used technique to investigate secondary structure and conformational
changes upon interaction with substrates (Fahmy, Siebert et al. 1995; Siebert
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1995; Zvyaga, Fahmy et al. 1996). However, the standard FTIR technique
(transmission mode) is limited to studying thin films to avoid the strong
background IR absorbance of water. FTIR in an attenuated total reflection (ATR)
mode solves this problem and allows for solvent accessibility to the protein. But
FTIR-ATR studies too have been limited by difficult sample preparation (poor
protein film formation, hydration induced swelling of sample and lack of
preservation of protein native state). The signal to noise ratio in a typical FTIRATR experiment is sufficient to study protein multilayers but not monolayers.
Surface enhanced infrared absorption spectroscopy (SEIRA) is a modification of
the FTIR-ATR method that can reliably measure spectra in protein monolayers
(Ataka and Heberle 2006). The SEIRA technique involves enhancement of the
interaction of IR by the sample with surface plasmons (collective electronic
oscillations from a colloidal metal film). The signal enhancement is restricted to
8-10 nm above the colloidal metal surface; therefore the bulk solution is not
enhanced. The enhancement of signal is affected by the size, shape and proximity
of the protein ‘islands’ to the metal film, provided that the islands are smaller than
the wavelength of IR light (15-30 nm).
For SEIRA measurements, a colloidal gold film is used as the surface. The
surface is often modified with linkers to avoid protein denaturation and to provide
selective protein orientation for measurements. The gold film used for SEIRA
may be conveniently modified with Ni-NTA groups. The NABB system meets all
the criteria to be an ideal sample for SEIRA studies. They are small in size, may
have a high concentration of proteins incorporated per NABB and the zap1 is
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histidine tagged, which can easily bind to a Ni-NTA surface. Accessibility to both
sides of the incorporated receptor is preserved for studies of complex
conformational changes. Initial experiments with rho-NABBs have shown that the
NABBs oriented parallel to the gold surface (probably due to two his tags per
NABB), and no significant loss in the rhodopsin IR spectrum was detected (Vogel
R- unpublished results).

7.2.2 Single-molecule Fluorescence of GPCRs

‘Nanosizing’ a traditional bulk-phase assay may lead to previously
unanticipated results. For example, a notable decrease in G protein activation
rates was reported in the presence of excess ‘empty’ HDL particles in assays
where rhodopsin were incorporated in HDL-like nanodisc particles (Bayburt,
Leitz et al. 2007). The reason of the lower rate of activation was hypothesized to
be partitioning of Gt into empty NABBs. Using 2-adrenergic receptor monomers
in HDL particles, and in the absence of empty HDL particles, only 6% of the total
Gs was bound to 2-AR containing HDL particles (Whorton, Bokoch et al. 2007).
In this case, it was hypothesized that excess Gs precipitates in the absence of
sufficient number of HDL particles, probably due to the hydrophobic
modifications present on Gs. In our experience with ensemble G protein assays
with rho-NABBs, we observed lower activation rates in the presence of empty
NABBs using the Trp fluorescence assay. Using the high-throughput BODIPYFL-GTPS assay with CCR5-NABBs, we did not observe a significant change in
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G protein activation in the presence or absence of empty NABBs. Further, our
control experiments using rho-NABBs did not show any difference in the basal
BODIPY-GTPS binding rate of Gt in buffer alone or Gt in the presence of empty
NABBs (Grunbeck A- unpublished data).
Fluorescence measurements carried out at single-particle resolution can
provide information of structural distributions in a direct fashion, since emitted
photons from individual molecules can be recorded and analyzed. The molecular
systems can be studied in a molecule-by-molecule manner, which enables
evaluation of biological processes in a model-free fashion (Mukhopadhyay and
Deniz 2007). The well-defined structure of NABBs and the ability to study
individual GPCRs either under constant flow conditions or by tethering the
NABBs to a functionalized surface make this an ideal system for single-molecule
fluorescence assays.
Single-molecule fluorescence studies also require the use of a novel class
of fluorophores that are photostable to intense laser excitation and do not form
non-emitting triplet states upon excitation (Eggeling, Fries et al. 1998). We have
used the Atto-655 dye for derivatization of rhodopsin (Chapter 4), which is part of
a series of dyes that fulfill the characteristics above and are hence ideally suited
for single-molecule fluorescence studies. Atto-655 is an oxazine-backbone based
dye that has lower molecular weight than most commercially available dyes that
are fluorescent at long wavelengths. The Atto dyes have been reported to show
significantly lower self-quenching, and have a rigid backbones that do not show
cis-trans isomerization common to cyanine based fluorophores (usually, only the
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trans conformation of a fluorophore is responsible for its fluorescence properties).
Quantitative studies of GPCRs in NABBs will thus depend on a combination of
ensemble assays like those presented in the preceding chapters, alongwith singleparticle techniques using appropriate fluorophore reporters, to understand signal
transduction events at a level proximal to the GPCR.

7.3

Future Research Aims

7.3.1 G protein Effects on Ligand Affinity of a GPCR

How can we detect a small change in ligand affinity of a GPCR under the
influence of purified G proteins using an ensemble fluorescence assay? When
fluorescently modified ligands are available (for example, RANTES for CCR5),
the sensitive technique of fluorescence anisotropy may be used to determine even
small changes in the anisotropy of the labeled ligand (in this case, a chemokine).
In a homogeneous solution the ground-state fluorophores will all be randomly
oriented. When exposed to polarized light, those fluorophores which have their
absorption transition moments oriented along the electric vector of the incident
light are preferentially excited (Lakowicz 1999). Hence, the excited state
population is no longer randomly oriented. Depolarization of emission can be
caused by a number of phenomena. Depending upon the conditions of this type of
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experiment, depolarization may be chiefly be determined by the rotational
diffusion of the fluorophore (attached to the ligand).

To measure fluorescence anisotropy (r), the sample is excited with
polarized light and the intensity of emission is measured through a polarizer.
r=

I||  I
I|| + 2I

where, I|| is the measured intensity when the emission polarizer is oriented
parallel to the direction of the polarized excitation, and I is the measured
intensity when the polarizer is perpendicular to the excitation polarization.
The labeled molecule is considered a spehere for the purpose of
calculating the average anisotropy in the sample. Following pulsed excitation, the
decay of fluorescence anisotropy, the decay of fluorescence anisotropy of a sphere
is given by:

r(t) = r0et /
where r0 is the anisotropy at t = 0 (also called fundamental anisotropy).

 is the rotational correlation time of the sphere, given by
=

V
RT

where  is the viscosity, V is the volume of the rotating unit,
T is the temperature in Kelvin and R is the gas constant.
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Considering the simplest mode of anisotropy, where the intensity follows
a single-exponential intensity decay, the expression for measured anisotropy r
(derived from Perrin equations) (Lakowicz 1999) is:
r=

r0
1+ ( / )

where  is fluorescence lifetime of the fluorophore. If the correlation
time is larger than the lifetime (  >>  ) then r= r0 . If the correlation time is
shorter than the lifetime (  <<  ), then r = 0.
For globular proteins, the rotational correlation time is related to the
molecular weight (M) by:

=

V M
=
(v + h)
RT RT

where v is the specific volume of the protein (typically 0.73 mL/g) and h
is the hydration (near 0.23 g of H2O per gram of protein).
For small fluorophores in a low viscosity solution, the emission is highly
depolarized because of very low rotational correlation times (determined by
molecular weight, as described above). The average molecular weight of a
fluorescently labeled chemokine is 8 kD. Upon binding to CCR5 in NABBs, the
molecular weight of the fluorophore-containing system increases to around 250
kD, or roughly 30 times the mass of the fluorescent chemokine alone. The NABB
not only stabilizes the CCR5, but in this case, adds the required bulk to increase
the rotational diffusion time of the bound fluorophore resulting in a net increase in
anisotropy, compared with a free (unbound) ligand. A heterotrimeric G protein
bound to the CCR5-NABB will increase the molecular mass of the system even
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further. Using this assay with an appropriately chosen fluorophore, it could be
possible to detect changes in ligand binding to CCR5 by the relative change in
anisotropy signal of the fluorophore as a measure of binding affinity to the CCR5NABBs.

7.3.2 Functional Consequences of GPCR Dimerization

NABBs may be designed to contain one or two GPCRs based on the
stoichiometry of GPCR to zap1 and lipids. The NABBs are formed by a selfassembly process mediated by hydrophobic association of the zap1 with the lipid
acyl chains and extensive salt-bridging between two anti-parallel, amphiphatic
alpha-helices of zap1, resulting in a soluble, disocidal structure of lipids with the
GPCR(s) incorporated. NABB assembly starts from a detergent solubilized state
of GPCR, lipids and zap1, therefore any artifactual aggregation of the GPCR with
other protein components can be minimized. The NABBs with or without the
GPCR may be affinity purified on Ni-NTA beads, or the affinity tag on the GPCR
may be used to obtain high purity of GPCR containing NABBs. In chapter 5, we
have characterized rhodopsin-NABBs using a variety of biophysical and
biochemical methods to detect G protein activation by one or two rhodopsins in
NABBs. We have demonstrated that a GPCR in NABBs has significantly higher
thermal stability compared to commonly used detergents (Chapter 5, 6). We have
also developed a method to rapidly incorporate CCR5 in NABBs from solubilized
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HEK-293 cell membranes, thereby minimizing the exposure of the GPCR to
detergents (Chapter 6).
Knowledge of the GPCR oligomeric state responsible for G protein
activation may be key to a novel class of therapeutic interventions, which perform
either by blocking GPCR dimerization directly or by modulating G protein
affinity for one of the oligomeric states. It is difficult to distinguish between
dimerization requirements for trafficking and for G protein activation using cellbased assays. NABBs may be used to isolate one or two GPCRs to perform G
protein activations in ultra small volumes and concentrations of all components.

7.3.3 Structures of a GPCR–G protein Assembly in a NABB

The study of membrane proteins in general, and GPCRs in particular, has
been hampered by the lack of a well-defined, soluble, model membrane. In the
absence of a membrane, even relatively soluble membrane proteins tend to
oligomerize or aggregate. On the other hand, if liposomes or detergent micelles
are used to stabilize proteins, the situation is complicated by these systems’
inherent polydispersity, inconsistency and instability. It has therefore been
challenging to obtain unambiguous information about GPCR structure and
function experimentally. NABBs may serve as a versatile adjunct to and extend
the use of conventional membrane technologies.
Electron microscopy is a powerful emerging field of image-based
structure deconvolution. Over the last decade, a convergence has taken place
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between the diverse fields of statistical optics, theory of linear systems, and
multivariate data analysis and classification with EM imaging (Frank 2002).
Determination of structure at a biologically meaningful resolution with singleparticle averaging techniques requires a good control of sample preparation
(homogeneous sample) and classification methods (often more than one method).
Negative stain EM is useful mainly for revealing only the surface contour of a
protein (Henderson 1995). This is because predominantly low-resolution
information is preserved by the negative stain due to the limitations associated
with embedding a biological sample in a heavy-ion based high contrast medium.
While we were able to perform a visual classification using negative-stained
NABBs (Fig. 5-4), the lipoprotein particles had sufficient heterogeneity in shape
to be intractable to more rigorous statistical analyses or structure prediction
(Appendix Fig. A). In cryo-EM, the molecules are entrapped in their native
orientation in a layer of vitreous ice. The densities measured in cryo-EM reflect
the projections of the biological material without any staining agent around the
particle. However, while using charged lipoproteins like NABBs made with
POPC as the lipid, the strong electron density of the lipid headgroups overwhelms
the densities of proteins that are not sufficiently separated from the lipid bilayer.
Cryo-negative staining may be a promising technique that would reverse the
strong electron density of the lipid headgroups under cryo-EM conditions, and
allow acquisition of medium to high resolution structural data of membrane
proteins incorporated in these discoidal lipoprotein particles.
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NMR

spectroscopy

is

a

complementary

technique

to

X-ray

crystallography for high resolution structure determination. NMR of discoidal
lipoprotein complexes presents the challenge of long rotational correlation times
of the relatively large sizes of lipoprotein complexes to be solved by solution
NMR. Solid-state NMR (SSNMR) has evolved as a powerful tool for structural
studies of protein and large complexes with slow tumbling rates. The limitation of
using isotope labels at a small number of sites on a protein in SSNMR has been
overcome in the last decade by the introduction of high magnetic field (greater
than 14 Tesla) and high-frequency magic-angle spinning (MAS) in combination
with multi-dimensional dipolar recoupling sequences (Opella and Marassi 2004).
NMR on lipoprotein particles has been successfully performed (Li, Kijac et al.
2006; Mishra, Anantharamaiah et al. 2006) although full assignments of the peaks
have not been reported in the case of membrane protein embedded in these
structures (Kijac, Li et al. 2007).

7.3.4 Tailoring Apolipoproteins to form NABBs of Diverse Properties

Apolipoproteins are called protein detergents for their unique ability to
form defined discoidal lipoprotein complexes. How can the properties of apo A-I
be modulated to form discs that have long-term stability, or are able to be
triggered to fuse and deliver their cargo (for example, to a Giant Unilamellar
Vesicle)? The amino-acid sequence of apo A-I is well-conserved throughout
evolution. Exploring apo A-I sequences of animals that evolved differently may
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provide us with clues as to which regions in the sequence may be critical for
stability of the structure. In one such attempt, the lipid binding helical stretches in
human apo A-I were repeated in different numbers to form a series of engineered
constructs called Membrane Scaffold Protein (MSP) series by the Sligar group
(Denisov, Grinkova et al. 2004). However, the net effect of these duplications was
not observed on the weighted salt-bridging scores, indicating that this strategy
may not be sufficient to increase disc stability. Methods to detect small changes in
disc stability and lipid affinity will also have to be developed simultaneously.
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APPENDIX A

3D Model of 2Fab-rho-NABB from Negative stain EM images

The EMAN suite of programs (Lüdtke, Baldwin et al. 1999) was
used to determine a preliminary structure of purified 2Fab-rho-NABBs
(Chapter 5). 12 electron micrographs were used to select 516 single
particles using the Boxer program. The defocus of the micrographs was
approximately
-5 μm. The selected particles were arranged into 8 class averages, and
these classes were averaged to give the final model as shown. A C6 axis of
symmetry perpendicular to the plane of the assumed disc was imposed
during calculation of the 3D model in order to converge the calculations to
form a cylindrical shape. The volume errors arising from the ‘commonlines’ approach to calculating the structure was not corrected for. The
model was not refined any further.
A barrel shape of the 2Fab-rho-NABB complex can be seen. The
outline of the NABB can be discerned from the structure. The smear of
density above and below the plane is likely due to C6 symmetry imposed
while calculating the model.
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APPENDIX B

Sandwich ELISA Calibration using Rho-NABBs

Detection of 1 rho-NABBs may be done using the sandwich
ELISA technique (Chapter 6). 6xHis antibody was used to capture NABBs
and 1D4-HRP was used to detect the rhodopsin present. (A) Scatter plot of
log of the rho concentration in NABBs in each well (x-axis) vs the
percentage of the maximum fluorescence intensity obtained. Each point is
the average of 4 wells. Black points show binding of 1D4 purified 1 rhoNABB (from a 0.01 rho/NABB sample) and red points show binding of
0.01 rho/NABB (including excess NABBs) to 1μg/mL of 6xHis antibody
inside the microplate wells. Rho-NABBs compete for 6xHis binding with
empty NABBs as seen by the requirement of higher rho concentration to
achieve the same signal when excess empty NABBs are present (red). (B)
Image of the microplate region corresponding to the black data points in
(A) using a Typhoon 9400 scanner showing the fluorescence intensity of
the Amplex Red product as a function of rho concentration. The sample
plate was prepared by serially diluting 10nM of rho in NABBs (rightmost
wells) from right to left.
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